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Abstract 
 The objective of this thesis was to test the hypotheses that in medicated, 
borderline-Stage 1 hypertensive individuals, 8 weeks of isometric handgrip (IHG) 
training (3X/week) would elicit reductions in resting and ambulatory blood pressure 
(BP), and that these reductions would be predicted by cardiovascular reactivity to an IHG 
task (a 2-minute sustained isometric contraction). Additionally, it was hypothesized that 4 
weeks of detraining following 8 weeks of IHG training would lead to BP returning to 
baseline values. Cardiovascular reactivity to an IHG task was determined prior to IHG 
training, while resting BP and ambulatory BP were determined prior to and following 8 
weeks of IHG training, and again after 4 weeks of no training (n = 4; resting BP:  134/77 
± 14/10 mmHg; age: 58 ± 2 years). IHG training did not elicit statistically significant 
reductions in BP (P > 0.05), and BP did not change following 4 weeks of detraining. Pre-
IHG training cardiovascular reactivity to the IHG task was not strongly correlated to IHG 
training-induced changes in resting or ambulatory BP.  
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1.1 Cardiovascular Disease 
Cardiovascular disease (CVD) encompasses all disorders of the heart and 
circulatory system that interfere with efficient functioning (Go et al, 2014). CVD includes 
conditions such as coronary heart disease, cerebrovascular disease, elevated blood 
pressure (BP) or hypertension (HTN), rheumatic heart disease and heart failure, and is the 
leading cause of death globally, as well as in Canada (Statistics Canada, 2015a; WHO, 
2017). Locally, CVD represented 35% of all causes of death between 2005-2007 in 
Windsor-Essex County, and the rate of mortality from CVD was 25% higher in Windsor-
Essex County in comparison to the province of Ontario (Statistics Canada, 2013). The 
medical costs of CVD in Canada amount to more than $20.9 billion per annum and are 
expected to rise to a total of $28.3 billion by the year 2020 (Conference Board of Canada, 
2010). Accordingly, the WHO considers the early prevention and treatment of CVD of 
the utmost importance (WHO, 2017). Realizing the potential in prevention, the Ontario 
government has created initiatives such as the Heart Health Program, one of the largest 
CVD prevention programs in North America that raises awareness of key lifestyle 
factors, such as diet, tobacco use, and exercise, which have been shown to alter the risk of 
CVD (Ontario Ministry of Health, 2012).  
 HTN is a leading modifiable risk factor for CVD, and has been deemed a global 
health crisis by the WHO (WHO, 2013). Closer to home, this is reflected by the fact that 
of the approximately 17 million CVD related deaths per year, 9.4 million are directly 
attributed to HTN (WHO, 2013). One in 5 Canadians have HTN, and in Windsor-Essex 
County, 27% of individuals aged 45-64 years and 48% of individuals aged 65 years and 
over were reported to have HTN in 2012 (Wilkins et al., 2010; Windsor-Essex County 
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Health Unit, 2016). With the percentage of people aged 50 years and over increasing each 
year in Canada, the number of individuals diagnosed with HTN will likely continue to 
rise (Statistics Canada, 2015b). 
1.2 Hypertension 
 Arterial BP is composed of systolic BP (SBP) and diastolic BP (DBP), which 
represent different phases of the cardiac cycle (Herd, 1970). SBP represents the 
maximum pressure the blood is exerting against the arterial walls when the heart beats, 
while DBP indicates the pressure that is exerted on the arteries when the heart is 
relaxed between beats (American Heart Association, 2016). Mean arterial pressure 
(MAP) represents the average BP during a single cardiac cycle (Zheng et al., 2008). 
Normal values of resting SBP and DBP for adults are <120 mmHg and <80 mmHg, 
respectively (American Heart Association, 2016). BP that is persistently elevated 
above normal measures is known as HTN, which is classified by measurements of SBP 
≥140 mmHg and/or DBP ≥90 mmHg (American Heart Association, 2016). However, 
recent evidence has shown that resting BP measures of SBP ≥135 mmHg and/or DBP 
≥85 mmHg are a more accurate threshold when diagnosing HTN using an automated 
office blood pressure (AOBP) device (Myers et al., 2015). Using Ambulatory BP 
monitoring (see Section 1.2.4), individuals can be diagnosed as hypertensive if mean 
awake SBP is ≥135 mmHg and/or DBP is ≥85 mmHg, or if mean 24-hour SBP is ≥130 
mmHg and/or DBP ≥80 mmHg (Leung et al., 2016). Individuals with pre-HTN or 
borderline HTN have SBP between 120-139 mmHg and/or DBP between 80-89 
mmHg (Leung et al., 2016). Arterial BP within the range of 140-159/90-99 mmHg is 
classified as Stage 1 HTN, whereas arterial BP >160/100 mmHg is defined as Stage 2 
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HTN (Dosh, 2001).  
HTN can be classified as either primary or secondary HTN. Primary or 
essential HTN represents approximately 95% of all cases of HTN, and appears to be 
caused by, “a complex interaction of genetics and environmental factors, including 
obesity, low physical activity levels, high stress levels, high alcohol consumption, 
high dietary sodium, and low dietary potassium” (Dosh, 2001). Secondary HTN is 
defined as high BP from secondary causes such as chronic renal disease, renovascular 
disease, or hyperaldosteronism (Dosh, 2001).  There is also a difference between 
controlled or uncontrolled HTN. Controlled HTN is considered to be resting BP 
<140/90 mmHg while on medication or another form of treatment, whereas 
uncontrolled HTN represents a resting BP ≥140/90 mmHg (Wang & Vasan, 2005). 
Patients with uncontrolled HTN may be on antihypertenisve medication, have poor 
treatment adherence, and/or an inadequate treatment regimen (Calhoun et al., 2008). 
Uncontrolled HTN can be further classified as resistant HTN (RHTN), which is 
defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg on maximally tolerated doses of 
three or more antihypertensive medications, one of which must be a diuretic (Calhoun 
et al., 2008). Most guidelines also require the need for daytime ambulatory BP 
monitor readings of SBP ≥135 mmHg or DBP ≥85 mmHg in order to confirm RHTN 
(Calhoun et al., 2008). 
As noted above, HTN has been identified as a primary risk factor for the 
development of CVD (Lawes et al., 2008; Brook et al., 2013). HTN is a major cause of 
morbidity and mortality, affecting over 26.4% of adults worldwide (Kearney et al., 
2005), and is responsible for 13.5% of deaths of the global population (Lawes et al., 
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2008).  In addition, up to 50% of individuals with HTN in Canada and the United 
States may have uncontrolled HTN (Wang & Vasan, 2005; Campbell et al., 2013). Due 
to its association with CVD related events such as coronary artery disease and stroke, 
the WHO deemed HTN a global health crisis and predicted an epidemic of HTN in the 
near future (WHO, 2013).  
1.2.3 Blood Pressure Regulation 
Regulation of BP is associated with the manipulation of several cardiovascular 
parameters, with the product of cardiac output (Q) and total peripheral resistance (TPR) 
representing MAP (MAP = Q x TPR) (Singh et al., 2010). Q represents the volume of 
blood pumped out of the heart per minute, which is the product of stroke volume (SV) 
and HR (Q = SV x HR) (Raven & Chapleau, 2014). TPR represents the opposition of 
blood flow through the systemic blood vessels (Raven & Chapleau, 2014; Charkoudian et 
al., 2005). Therefore, changes in BP are the result of changes in Q via increases or 
decreases in HR and/or SV, and in TPR via changes in arterial diameter through 
vasodilation or vasoconstriction of vascular smooth muscle (Singh et al., 2010). The 
autonomic nervous system (ANS) and endocrine reflexes are the main regulators of BP 
control (Gordan et al., 2015).  
Autonomic Nervous System 
 As part of the peripheral nervous system, the ANS can regulate BP, HR, 
respiration rate, sweating, in addition to other autonomic functions to maintain 
homeostasis (Gordan et al., 2015). The ANS is composed of two interconnected systems: 
the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS) 
(Gordan et al., 2015). The effect of the ANS on BP is a constant balance between the 
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opposing effects of the SNS and the PNS. 
 The SNS prepares the body for stressful situations (known as the “fight or flight” 
response) (Gordan et al., 2015). Upon activation, the SNS releases norepinephrine (NE), 
which causes blood vessel constriction, and increased BP (Gordan et al., 2015). SNS 
activation also increases contractility of the heart by increasing intracellular calcium 
(Ca2+), as well as enhancing the conductance of the electrical signals within the heart 
(Gordan et al., 2015). NE binds to two types of adrenergic receptors (ARs) within the 
SNS, known as α and β ARs (Gordan et al., 2015). Both α1 and α2 ARs are expressed in 
vascular smooth muscle and both elicit vasoconstriction upon activation, thus increasing 
BP (Michel et al., 1990). β1 ARs are found in the heart and its activation elicits increased 
HR, myocardial contractility, and electrical conduction velocity within the heart, which 
leads to an increase in BP (Michel et al., 1990; Gordan et al., 2015). β1 ARs are found 
throughout the body, with their activation resulting in vasodilation (increased blood 
perfusion) in target organs, such as the heart, liver, and skeletal muscle (Gordan et al., 
2015).   
 Parasympathetic activity generally produces effects that oppose sympathetic 
activity, such as decreased HR, reduced conduction velocity through the heart, and 
ultimately lower BP (Gordan et al., 2015). The PNS releases acetylcholine (ACh) and is 
most active under resting conditions (Gordan et al., 2015). ACh binds to two types of 
muscarinic receptors within the PNS: the M2 and M3 receptors (Gordan et al., 2015). M2 
receptors are located in the heart and its activation via ACh binding reduces conduction 
velocity through the heart, thus reducing HR, SV, Q, and BP (Gordan et al., 2015). 
Activation of M3 receptors, mainly located in vascular endothelium, cause vasodilation 
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by stimulating nitric oxide (NO) production from endothelial cells (Brodde & Michel, 
1999; Gordan et al., 2015).  
 The ANS is made up several reflex arcs (Gordan et al., 2015). The central 
command (CC) is a control mechanism within the brain that sets the basic pattern of 
motor activity to skeletal muscles and drives cardiorespiratory activation by coordination 
with another region of the brain, the cardiovascular control centre (CCC) (Michelini et 
al., 2015). Activation of neural pathways within the CC modulates sympathetic and 
parasympathetic outflow from the CCC to change BP accordingly (Weippert et al., 2013).  
 Arterial baroreceptors located within the aorta and carotid sinuses are stretch 
receptors that detect changes in BP (Gordan et al., 2015). These stretch-sensitive 
baroreceptors send afferent information to the CCC to alter efferent sympathetic and 
parasympathetic neural output (Hart & Charkoudian, 2013). When BP is increased, these 
mechanoreceptors are activated via distension, and subsequently send signals to the CCC 
that causes sympathetic inhibition via vasodilation and parasympathetic activation 
(Gordan et al., 2015). This results in a decrease in TPR, HR, and Q, which returns BP 
back to the central set point (Gordan et al., 2015). In contrast, a reduction in BP reduces 
the frequency of afferent signaling from the baroreceptors to the CCC (Lafranchi & 
Somers, 2002). The CCC responds by withdrawing parasympathetic activity and 
increasing activity of sympathetic nerves (Hart & Charkoudian, 2013). This results in an 
increase in HR, SV, and Q, as well as an increase in TPR (vasoconstriction) to increase 
BP (Hart & Charkoudian, 2013).  
The partial pressures of oxygen (PaO2) and carbon dioxide (PaCO2), as well as the 
changes in hydrogen ion concentration ([H+]) are monitored by central and peripheral 
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chemoreceptors (O'Regan & Majcherczyk, 1982). Central chemoreceptors detect changes 
in PaCO2 and pH within the brain, whereas peripheral chemoreceptors are located within 
the carotid and aortic bodies to monitor PaO2, PaCO2, and pH of the blood (Gordan et al., 
2015). Both types of chemoreceptors are activated by an increase in PaCO2 and/or a 
decrease in pH (more acidic), which increases the number of impulses to the CCC, 
resulting in SNS activation and PNS inhibition to increase HR, SV, Q, TPR, and BP 
(Gordan et al., 2015). There are also receptors involved in BP regulation within muscles. 
The two main muscle afferent receptors are mechanoreceptors and metaboreceptors 
(Leshnower et al., 2001). Mechanoreceptors are group III afferent sensory neurons that 
are stimulated by the physical distortion due to the pressure changes within the arterial 
walls during muscle contraction (Murphy et al., 2011). Metaboreceptors are group IV 
afferent sensory neurons that are activated by the chemical by-products of muscle 
contraction, such as lactate, potassium (K+), and phosphate (Murphy et al., 2011). 
Mechanoreceptors are activated at the start of muscle contraction, whereas 
metaboreceptors are activated by the metabolites when the oxygen supply cannot meet 
the metabolic demands of the contracting muscle (Belli et al., 2011). Once activated, both 
types of receptors send impulses to the CCC, resulting in an increase in efferent 
sympathetic nerve activity and an inhibition of parasympathetic nerve activity in order to 
provide adequate oxygen and nutrient delivery to the contracting muscle (Murphy et al., 
2011). Taken together, these actions result in increases in HR, SV, Q, and TPR, thus 
leading to an increase in BP (Murphy et al., 2011).  
Endocrine Reflexes 
Several endocrine hormones that are produced and released by many different 
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parts of the body can also regulate of BP. Epinephrine (E) is produced in the adrenal 
glands and initiates the fight or flight response during sympathetic activation (Gordan et 
al., 2015). E binds to all major ARs, eliciting vasoconstriction (increased TPR) via α1 and 
α2 AR activation, as well as increased HR and contractility via β1 AR activation, thus 
increasing BP (Gordan et al., 2015).  
Vasopressin, also known as antidiuretic hormone, is produced in the 
hypothalamus, stored in the posterior pituitary gland, and released in response to a 
reduction in BP, plasma volume, or an increase in plasma osmolarity (Holmes et al., 
2004; Gordan et al., 2015). Within the kidney, vasopressin causes water retention by 
increasing water permeability, which increases blood volume, Q, and thus, BP (Nielson et 
al., 1995). Vasopressin is also a vasoconstrictor, which increases TPR and BP (Gordan et 
al., 2015).  
The renin-angiotensin-aldosterone system (RAAS) regulates BP and fluid balance 
(Gordan et al., 2015). Once a decrease in blood volume or BP is detected, renin is 
released from the kidneys and converts the liver angiotensinogen into angiotensin I 
(Nguyen et al., 2002). Angiotensin I is further modified by angiotensin converting 
enzyme (ACE) into angiotensin II, the active form of the hormone. Angiotensin II is a 
potent vasoconstrictor that directly raises BP by increasing TPR (Nguyen et al., 2002). It 
also acts on the kidneys to increase sodium reabsorption, which increases water retention 
and BP (Gordan et al., 2015). Angiotensin II also stimulates aldosterone release from the 
adrenal cortex, causing sodium retention and leads to an increase in blood volume and BP 
(Gordan et al., 2015).   
 Atrial natriuretic peptide (ANP) is a cardiac hormone that increases BP (Gordan 
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et al., 2015; Potter et al., 2009). Its release is caused by distension of the atria, β-AR 
stimulation, or increases in angiotensin II, which all lead to an increase in BP (de Bold, 
1985).  
Endothelin-1 (ET-1) is a potent vasoconstrictor produced by endothelial cells and 
can counterbalance the activity of local vasodilatory substances (Touyz & Shiffrin, 2003; 
Gordan et al., 2015). ET-1 is produced in response to chemical (e.g. angiotensin II or 
catecholamines) or mechanical (e.g. shear stress) stimulation of the endothelium (Touyz 
& Shiffrin, 2003). Depending on the receptor ET-1 binds to, it can either induce smooth 
muscle vasoconstriction, resulting in increases in TPR and BP, or cause vasodilation via 
NO release, thus decreasing TPR and BP (Pollock et al., 1995; Gordan et al., 2015).  
Other Factors Regulating Blood Pressure 
The concentration of K+ within skeletal muscle is important to the regulation of 
BP (Lindinger & Sjogaard, 1991). An increase of [K+] in the interstitial space causes 
vasodilation of the vascular bed to help deliver nutrients to the contracting muscle and 
remove waste products from it, thus reducing TPR and BP (Lindinger & Sjogaard, 1991).  
When adenosine triphosphate (ATP) is broken down during smooth muscle 
contraction, its by-products accumulate, such as adenosine diphosphate, adenosine 
monophosphate, and adenosine (Haddy & Scott, 1968). During muscle contraction, an 
increased concentration of adenosine induces vasodilation through its action on the 
adenosine receptors, thus reducing TPR and BP (Ballard et al., 2014).  
1.2.4 Blood Pressure Measurement  
The most accurate measure of resting BP involves the insertion of a catheter into 
the radial artery with a pressure transducer attached to the catheter providing direct 
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measures of SBP, DBP and MAP (Parati et al., 1989). However, this costly and invasive 
procedure requires specialized training, which discourages its use in a clinical setting 
(Parati et al., 1989). Two of the more practical and commonly employed techniques in 
clinical practice include auscultatory sphygmomanometry and oscillometry (Dieterle, 
2012). Both methods are non-invasive and are measured at the level of the brachial artery 
(Dieterle, 2012). A novel form of oscillometry known as ambulatory BP monitoring has 
recently gained interest in the clinical community, with evidence suggesting that it is a 
more reliable measure of BP (Pickering et al, 2005; Sherwood et al., 2012). 
Auscultatory Sphygmomanometry 
For decades, auscultatory sphygmomanometry was considered the gold standard 
for BP measurement in clinical practice and clinical research (Campbell et al., 2014; 
Dieterle, 2012). It is a non-invasive method of BP measurement that utilizes a cuff and 
sphygmomanometer to detect Korotkoff sounds (Dieterle, 2012; Beevers et al., 2001). 
However, even with adequate training, it is difficult to ensure accurate measurements 
with this technique since it requires adequate hearing and concentration to interpret 
Korotkoff sounds (Campbell et al., 2014). This type of BP measurement can also lead to 
observer measurement bias, which is when the observer simply adjusts the pressure to 
meet their expectation (Beevers et al., 2011). Due to these limitations that can lead to the 
misdiagnosis of HTN, auscultatory sphygmomanometry is not as reliable and accurate as 
intra-arterial BP measurements (Pickering et al., 2005).  
Oscillometry 
 Similar to auscultatory sphygmomanometry, oscillometry is a non-invasive 
method that uses cuff inflation to measure BP in AOBP devices (Campbell et al., 2014; 
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Dieterle, 2012). This technique differs from auscultatory sphygmomanometry in that it 
employs a microprocessor to detect oscillatory signals (Shahriari et al., 2003). The 
oscillometric technique has a number of advantages in comparison to auscultatory 
sphygmomanometry, such as it being less susceptible to external noise disturbance, not 
relying on human auditory acuity, and not requiring a transducer, which makes the 
accuracy of cuff placement less critical (Ogedegbe & Pickering, 2010; Pickering et al., 
2005). A limiting factor of auscultatory sphygmomanometry is that the algorithms used 
for detecting SBP and DBP from MAP are different from one device to another, and are 
not disclosed by the manufacturers (Pickering et al., 2005). However, when compared to 
auscultatory sphygmomanometry and intra-arterial measurements, the oscillometric 
technique has shown generally good agreement in terms of BP measurement accuracy 
(Pickering et al., 2005). This is evident by the fact that the AOBP is now the preferred 
method of measuring in-office BP (Leung et al., 2016). 
Ambulatory Monitoring 
 Ambulatory BP monitoring uses the oscillometric technique as described above, 
but can record BP for 24 hours or longer (O’Brien et al., 2001). The same placement of a 
cuff around the upper arm for assessment of BP at the brachial artery is used, however, 
the cuff is attached to a monitor by a hose and is programmed to inflate at set time 
intervals throughout the prescribed measurement period (O’Brien et al., 2001). The 
ambulatory monitor is generally programmed to measure BP every 30 minutes during the 
day (6:00 AM – 10:00 PM), and every hour during the night (10:00 PM – 6:00 AM) 
(Pickering et al., 2006). The BP measures are recorded by the monitor and can be 
uploaded to a computer to generate mean daytime, nighttime and 24-hour BP 
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measurements (Pickering et al., 2006; O’Brien et al., 2003).  
 There has been a growing emphasis on BP readings taken outside of the clinical 
setting to prevent the white coat effect, which is a phenomenon that leads to increased BP 
readings at the clinic visit, but normotensive BP readings outside of the clinical setting 
(Ogedegbe & Pickering, 2010). For example, a study by Graves and colleagues (2003) 
reported a mean manual BP taken in a clinic to be 152/84 mmHg, while the mean 24-
hour ambulatory BP was 138/74 mmHg. Therefore, ambulatory BP monitoring can be 
used to rule out white-coat HTN and produce a more reliable measure of BP (Drawz et 
al., 2012). Additionally, BP measurements taken in a health care provider’s office are 
affected by random error, systematic error, as well as several other physiological 
variables that can affect the patient during the day, whereas BP measurements at night are 
considered to be basal BP and represent the true BP status of an individual (Mahabala et 
al., 2013).  
 Ambulatory BP monitoring can also provide greater insight into the efficacy of 
antihypertensive medications and the overall changes the medication produces in the BP 
profile by measuring BP during sleep, an increasingly important prognostic parameter for 
CVD risk (O’Brien et al., 2001; Boggia et al., 2011). In healthy individuals, BP follows a 
circadian pattern (Panza et al., 1991). At night, a slight reduction or “dip” of BP is a 
normal physiological change that can be blunted by CVD risk factors (Mahabala et al., 
2013). A patient with a fall >10% in SBP and DBP in the night in comparison to daytime 
readings is considered normal and is defined as a dipper (Peixoto & White, 2007). 
Patients with a nocturnal fall <10% are defined as nondippers (Peixoto & White, 2007). 
In the hypertensive population, a nondipping pattern is correlated with greater rates of 
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insulin resistance, increased arterial stiffness and increased risk of CVD (Birkenhager & 
Van den Meiracker, 2007; Anan et al., 2003; Cicek et al., 2013). Therefore, the dipping 
pattern can be used to investigate the secondary causes of HTN and determine the 
efficacy of antihypertensive therapies (Mahabala et al., 2013).  
1.2.5 Pathophysiology of Hypertension 
The progression to HTN results from a combination of environmental, genetic and 
behavioural factors (DeMarco et al., 2014). Dysfunction in one or more of the BP 
regulatory pathways can play a role in the development of primary HTN. Several studies 
have discovered a link between a dysfunctional ANS and HTN development (Singh et al., 
2010; Julius & Schork, 1978). A dysfunctional ANS can cause the SNS to be chronically 
activated, which can contribute to HTN by its effects on the heart, vasculature, and 
kidneys (Mark, 1996). An over-active SNS is the main reason that most patients with 
essential HTN have higher levels of circulating plasma catecholamines (E and NE) in 
comparison to normotensive controls (Goldstein, 1983). This SNS stimulation via NE 
release from the adrenals results in peripheral vasoconstriction (increased TPR), 
increased HR, and an elevated resting BP (Singh et al., 2010). A dysfunctional ANS can 
also decrease parasympathetic activity, which reduces cardiac vagal drive (Mancia & 
Grassi, 2014). This reduced vagal inhibitory influence on the sinus node can lead to 
chronic elevations of HR and BP (Julius et al., 1971).  
As mentioned previously, the arterial baroreflex has an important role in the 
regulation of BP. However, chronically high BP results in a stiffer carotid arterial wall, 
causing the more rigid carotid sinus to be less distensible during a BP increase 
(Honzikova & Fiser, 2009; Singh et al., 2010). This is supported by the fact that 
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hypertensive individuals have decreased baroreflex sensitivity in comparison to the 
normotensive population (Honzikova & Fiser, 2009). Since baroreceptors are a type of 
mechanoreceptor that are stimulated by distension of the carotid wall, decreased 
baroreflex sensitivity means less activation of the baroreceptor, leading to a chronically 
elevated BP set-point (Honzikova & Fiser, 2009). With respect to the RAAS, deviation 
from normal function can cause the overproduction of circulating renin (Singh et al., 
2010). This causes an increased production of angiotensin II and aldosterone, which both 
contribute to HTN development via increased vasoconstriction and water retention, 
respectively (Singh et al., 2010; Beevers et al., 2001).  
There are many other factors that can contribute to the raised BP seen in the 
hypertensive population. Insulin resistance is also an underlying mechanism that 
contributes to the progression of HTN, as well as renal complications in obesity and 
diabetes (Aroor et al., 2013). Obesity contributes to HTN, since an increased BMI is 
associated with an increase in plasma volume and Q, which can both increase BP 
(Carretero & Oparil, 2000; DeMarco et al., 2014). Obesity and a sedentary lifestyle 
promote insulin resistance, a condition with impaired insulin metabolic signaling 
response to the liver, skeletal muscle, and adipose tissue (Sowers, 2013; DeMarco et al., 
2014). This impairment of signaling decreases the bioavailability of NO, which reduces 
endothelial-mediated vascular relaxation, causing an increase in TPR and BP (Sowers, 
2013). Although obesity is a significant factor associated with insulin resistance, non-
obese subjects with HTN are still much more likely to exhibit insulin resistance in 
comparison to normotensive individuals (Modan et al., 1985). Therefore, it is evident that 
there are many interrelated factors that contribute to HTN, with the probable role of these 
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factors differing among individuals (Beevers et al., 2001). 
Other lifestyle factors that contribute to essential HTN development include high 
alcohol intake, high salt intake, low physical activity, low K+ intake and low Ca2+ (Sever 
& Poulter, 1989; Carretero & Oparil, 2000). Aging is considered a major non-modifiable 
risk factor in the development of HTN, with studies reporting a significant correlation 
between aging and increased BP (Harvey et al., 2015; Wang et al., 2010). This increased 
risk of HTN from aging is due to vascular changes, which causes endothelial dysfunction 
and increased vascular stiffness (Harvey et al., 2015).  
Sex differences can also have an impact on the regulation of BP. Before 
menopause, women are better protected from most cardiovascular events compared to 
men (Maranon & Reckelhoff, 2013). After menopause, postmenopausal women are at 
increased risk of cardiovascular complications compared to premenopausal women and at 
a similar risk to aged-matched men (Maranon & Reckelhoff, 2013). The sex-based 
mechanisms for HTN development are not as simple as the presence or absence of 
androgens, since hormone replacement therapy in both sexes does not appear to provide 
prevention against cardiovascular events (Maranon & Reckelhoff, 2013).  
There are also differences in ethnicity that can contribute to HTN. In a recent 
meta-analysis of the North American population, it was shown that non-hispanic black 
individuals have higher rates of HTN in comparison to white individuals, while 
Indigenous, Chinese, Hispanic and Arab individuals had similar rates of HTN in 
comparison to white individuals (Gasevic et al., 2015).  
1.2.6 Prevention/Treatment of Hypertension 
Randomized controlled trials have convincingly shown that treatment of HTN 
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reduces the risk of stroke by approximately 30%, coronary heart disease by 10-20%, 
congestive heart failure by 40-50%, and total mortality by 10% (Wang et al., 2005). 
Meta-regression analyses have also shown relative risk reductions for major CVD 
events (stroke, heart failure, and all-cause mortality) to be proportional to the 
magnitude of BP reduction achieved (Ettehad et al., 2016; Lewington et al., 2002). 
More specifically, reductions as low as 2 mmHg in SBP can reduce the risk of 
coronary heart disease, stroke, heart failure, and all-cause mortality (Ettehad et al., 
2016; Lewington et al., 2002). In addition, reductions in nighttime BP have been 
associated with increased rates of a normal dipping pattern, significantly lower rates of 
CVD, and a decreased rate of all-cause mortality (Mehta & Drawz, 2011). 
This is supported by recent findings from the SPRINT Research Group who 
found that treating individuals over 50 years of age with HTN to a SBP target of <120 
mmHg in comparison to a target of <140 mmHg resulted in lower rates of fatal and 
nonfatal major cardiovascular events and death from any cause (SPRINT Research 
Group, 2015). The results of the SPRINT study add substantial evidence to the benefits 
of lowering SBP. The SPRINT study has influenced Canadian HTN guidelines, with 
the treatment goal for most adults with HTN being SBP <140 mmHg and DBP <90 
mmHg, while for select high-risk patients, the treatment involves a target of SBP <120 
mmHg (Leung et al., 2016). 
Engaging in healthy dietary habits and meeting the guidelines for physical 
activity are essential components in the prevention and management of HTN (Leung et 
al., 2016). Other lifestyle modifications include stress reduction, smoking cessation and 
limiting alcohol consumption (Khan et al., 2007). However, it was reported that over 
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60% of Canadians aged 12 years and older are not meeting the recommended daily 
intake of fruits and vegetables (Statistics Canada, 2015c). Regular physical activity has 
also been shown to be an integral element of maintaining a normal BP, but only 15% 
of adults are meeting the current exercise guidelines of 150 minutes of moderate to 
vigorous activity per week (WHO, 2017; Statistics Canada, 2014a).   
If such modifications are inadequate to generate an acceptable reduction in BP to 
within target ranges, pharmacological therapy is recommended in addition to lifestyle 
changes (Brook et al., 2013). Different classes of pharmaceuticals target different 
pathological mechanisms of HTN; common medications utilized include calcium channel 
blockers, ACE inhibitors, diuretics, and β-blockers (Chobanian et al., 2003). Calcium 
channel blockers bind to L-type calcium channels on vascular smooth muscle and cardiac 
tissue to prevent calcium ion influx into the cell membrane (Livada & Shiloah, 2013). 
Among other effects, this blockage causes vasodilation of vascular smooth muscle 
(decrease in TPR) and reduces HR, which both lead to a lower BP (Livada & Shiloah, 
2013). ACE inhibitors, which prevent the formation of the vasoconstrictor angiotensin, 
subsequently decrease TPR and BP (Sweitzer, 2003). Thiazides are the most common 
type of diuretic used for lowering BP (Duarte & Cooper, 2010). Thiazides decrease 
sodium reabsorption by inhibiting the sodium/chloride-cotransporter in the renal distal 
convoluted tubule (Duarte & Cooper, 2010). Acutely, this results in an increased loss of 
fluids in urine, which leads to decreased extracellular fluid and plasma volume, 
subsequently reducing Q and BP (Duarte & Cooper, 2010). Chronically, however, 
thiazides must lower BP through another mechanism since extracellular fluid and plasma 
volume are typically fully recovered within 6 weeks, yet BP reductions are maintained 
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(Duarte & Cooper, 2010). Although the mechanism has not been fully elucidated, it has 
been shown that thiazide diuretics decrease TPR, which maintains the BP reductions in 
the long term (Duarte & Cooper, 2010). Finally, β-blockers prevent catecholamines from 
binding to their receptor, causing the heart to pump with less intensity and a reduction in 
HR and BP (Frishman, 2003). Despite the multitude of pharmacologic treatments 
available, many Canadians treated pharmacologically for HTN still have BP above target 
ranges (Statistics Canada, 2014b).  
Adherence to lifestyle modifications, such as healthy eating and regular exercise, 
may also be difficult for certain populations due to physical limitations or lack of 
functional independence (Schutzer et al., 2004). These findings assert that current HTN 
interventions do not work for everyone. Novel interventions that can be used 
independently or as an adjunct to traditional therapies in order to treat HTN must be 
explored. 
1.3 Exercise Training 
 The Canadian Physical Activity Guidelines recommend at least 150 minutes of 
moderate to vigorous aerobic exercise per week in healthy adults over the age of 18 
years, with dynamic resistance exercise performed at least 2 days per week (Tremblay et 
al., 2011). These recommendations are supported by guidelines around the world 
(Thompson et al., 2013; Kahlmeier et al., 2015). For the hypertensive population, the 
most recent Canadian Physical Activity Guidelines from the Canadian Hypertension 
Education Program recommend 30-60 minutes of moderate intensity (40 to <60% of an 
individual’s HR reserve) aerobic exercise (e.g. walking, jogging, cycling, or swimming) 
4-7 days per week (Leung et al., 2016). The Canadian Hypertension Education Program 
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also prescribes dynamic resistance training (e.g. free weight lifting, or fixed-weight 
lifting) as an adjunct to aerobic exercise (Leung et al., 2016). Dynamic resistance training 
should be performed 2 to 3 times per week while completing 8-12 repetitions per 
exercise, while focusing on all major muscle groups (Thompson et al., 2013). Until 
recently, no guidelines or recommendations existed for a specialized form of resistance 
exercise, isometric resistance training (IRT). IRT involves sustained contractions against 
an immoveable load or resistance with minimal or no change in length of the muscle 
involved (Inder et al., 2016). As a result of accumulating evidence, the American Heart 
Association recently recommended IRT as an alternative method for lowering BP in their 
2013 Position Statement (Brook et al., 2013), and handgrip training was suggested as an 
adjuvant training regimen in the CHEP guidelines (Leung et al., 2016). The most 
common IRT protocol consists of four, 2-minute sustained contractions performed at 
30% of maximal voluntary contraction (MVC) on a handgrip dynamometer, known as 
isometric handgrip (IHG) training. Session durations range from 12-15 minutes per bout, 
and are performed at a minimum frequency of 3 times a week over a period of 8-10 
weeks (Brook et al., 2013). 
IRT also includes isometric leg (IL) exercise, which appears to elicit similar BP-
lowering benefits as the IHG. This protocol consists of individuals sitting in an upright 
position with a 90 degree flexion of the hip, and then multiple, timed leg extensions are 
performed at a set percentage of MVC (Brook et al., 2013; Baross et al., 2012; Devereux 
et al., 2010).   
1.3.1 Acute Effects of Exercise on Blood Pressure 
In general, an acute bout of exercise causes an increase in PaCO2 and [H+], which 
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will increase the frequency of impulses relayed to the CCC via afferent feedback (Gordan 
et al., 2015). This causes an increase in SNS activity and PNS inhibition, resulting in an 
increase in Q, HR, and vasoconstriction in the venous vasculature, which causes an 
augmentation in BP in order to restore blood supply to the working tissues (Mayo et al., 
1999; MacDonald, 2002; Joyner & Limberg, 2014). There are also receptors within 
skeletal muscle that help monitor BP and HR during exercise (Murphy et al., 2011). 
These receptors (mechanoreceptors and metaboreceptors) make neural-mediated 
cardiovascular adjustments through a peripheral reflex in the contracting muscles known 
as the exercise pressor reflex (EPR) (see Section 1.2.3) (Murphy et al., 2011).  
Aerobic exercise can cause increases in SBP >200 mmHg, while dynamic 
resistance exercise can cause increases of SBP and DBP up to 400 mmHg and 200 
mmHg, respectively (MacDonald, 2002; MacDougall et al., 1985). With respect to acute 
isometric resistance exercise, Araujo and colleagues (2011) had older, primarily coronary 
artery disease patients (n = 41; age = 64 ± 9 years; resting BP = 115/69 ± 11/10 mmHg) 
perform the IHG exercise (four, 2-minute bouts, 1-minute rests, 30% MVC) and reported 
modest increases in HR (3 ± 4 beats per minute) and BP (16/10 ± 7/6 mmHg). Wiley and 
colleagues (1992) investigated the effect of a 2-minute IHG contraction at 30% MVC in 
young normotensive individuals (n = 8; age = 20-35 years; resting BP = 134/87 ± 1/2 
mmHg) and found acute mean increases of 17/16 mmHg for SBP/DBP, respectively. In 
addition, Aoki and colleagues (1983) examined the BP response to an acute bout of IHG 
(3 minutes, 30% MVC) in normotensive (n = 18; age = 39 ± 3 years; resting BP = 
117//73 ± 6/5 mmHg) and non-medicated hypertensive (n = 50; age = 41 ± 4 years; 
resting BP = 162/105 ± 13/9 mmHg) men. It was reported that the hypertensive men had 
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a larger mean increase in BP during the IHG bout (45/30 mmHg) in comparison to the 
normotensive men (30/26 mmHg). Since the hypertensive population already has a higher 
initial BP and has been shown to display greater increases in BP during an IHG bout, 
caution should be used when working with this population.  
Recent work by Carlson and colleagues (2017) measured BP, HR, and rate 
pressure product, a measure of myocardial oxygen consumption in normotensive (n = 60; 
age = 39 ± 9 years; resting BP = 115/67 ± 11/7 mmHg) and pre-hypertensive (n = 60; age 
= 54 ± 7 years; resting BP = 131/75 ± 13/8 mmHg) individuals performing IHG (four, 2-
minute bouts conducted unilaterally in the non-dominant hand with 3-minute breaks 
between sets) at either 5%, 10%, or 30% of their MVC. No significant difference 
between groups were found for peak SBP, DBP, MAP, HR, or rate pressure product 
across any of the four bouts of IHG in any of the three groups (5%, 10%, or 30% MVC) 
(Carlson et al., 2017). Additionally, the low-to-moderate intensity of the IHG exercise 
has been shown to be safe, with no reports of lasting physical impairments or significant 
unfavourable clinical events in over 25,000 sessions recorded (Millar et al., 2014).  
  Acute exercise can cause SBP and DBP to decrease during the post-exercise 
period, a phenomenon referred to as post-exercise hypotension (PEH). This effect has 
been observed for up to 22 hours following bouts of aerobic exercise in both 
normotensive and hypertensive individuals, while up to 10 hours following bouts of 
dynamic resistance exercise in hypertensive individuals (Rondon et al., 2002; Melo et al., 
2006). Generally, it has been found that PEH occurs independently of exercise intensity 
when directly comparing exercise intensities, but it seems that a minimum intensity (e.g. 
30% of maximal exercise capacity) is needed to produce PEH (MacDonald, 2002). 
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Although there is evidence to support that that a longer duration of exercise produces a 
greater magnitude of PEH (45 minutes of aerobic exercise compared to 25 minutes) 
(Forjaz et al., 1998), the findings are preliminary and warrant further investigation 
(MacDonald, 2002). Average reductions in SBP/DBP of 8/9 mmHg and 10/7 mmHg 
immediately following a bout of aerobic exercise (PEH) have been reported in 
normotensive and hypertensive populations, respectively (MacDonald, 2002). Reductions 
in post-exercise BP in response to dynamic resistance exercise for SBP are similar to 
those of aerobic exercise, however changes in DBP remain inconclusive (Anunciacao & 
Polito, 2011). In aerobic exercise, the magnitude of BP reduction is proportional to pre-
exercise resting BP in both BP populations; individuals with the highest pre-exercise 
values experience the greatest reductions post-exercise, while those with the lowest pre-
exercise values experience the slightest reductions (Rondon et al., 2002). This effect has 
not been observed following dynamic resistance exercise (MacDonald, 2002). The 
mechanisms underlying PEH are elusive, but a sustained inhibition of sympathetic 
outflow and release of local vasodilatory substances have been implicated (MacDonald, 
2002).  
The effect of acute IRT exercise on PEH is under-investigated. A study conducted 
by Millar and colleagues (2009) observed PEH of SBP (3 mmHg) following four, 2-
minute sustained bilateral IHG contractions at 30% MVC in older normotensive 
individuals (n = 18; age = 70 ± 5 years; resting BP = 125/69 ± 4/1 mmHg). Additionally, 
O’Driscoll and colleagues (2017) examined the effects of isometric wall squats (four, 2-
minute holds with 2-minutes of rest in between each set) on non-medicated, pre-
hypertensive men (n = 26; age = 45 ± 8 years; resting BP = 133/78 ± 6/9 mmHg) and 
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found significant mean post-exercise reductions in SBP and DBP of 23 and 19 mmHg, 
respectively. Investigators noted that this bout of IRT lead to a significant improvement 
in cardiac function and mechanics acutely, which may be partly responsible for the 
observed BP reductions in IRT when used chronically (O’Driscoll et al., 2017). In 
contrast, PEH was not observed by Bartol and colleagues (2012) in well-controlled 
medicated hypertensives (n = 11; age = 60 ± 9 years; resting BP = 114/61 ± 13/12 
mmHg) within 22 hours following four, 2 minute sustained bilateral contractions at 30% 
MVC. These findings were replicated by Olher and colleagues (2013) in well-controlled 
medicated hypertensive elderly women (n = 12; age = 64 ± 1 years; resting BP = 121/72 
± 7/6 mmHg) following a bout of either four, 2 minute sustained bilateral contractions at 
30% MVC or four, 45 second sustained unilateral contractions at 50% MVC. The lack of 
a PEH response observed in this population may be attributed to the BP modulating 
effects of antihypertensive medication.  
1.3.2 Chronic Effects of Exercise on Blood Pressure 
The effectiveness of chronic exercise-induced reductions in resting BP has been 
well proven. Aerobic exercise interventions lasting ≥4 weeks have been shown to 
produce an average resting SBP/DBP reduction of approximately 2/2 mmHg and 6/5 
mmHg in normotensives and hypertensives, respectively, despite the utilization of 
various of exercise modalities (walking, running, cycling), intensities (45-86% of 
maximal oxygen reserve), durations (15-60 minutes) and frequencies (1-5 days per week) 
(Kelley et al., 2001). The weight of the evidence suggests that chronic dynamic resistance 
exercise reduces resting BP, although the amount of supporting evidence is not nearly as 
extensive as that with aerobic training (Cardoso et al., 2010). A meta-analysis of 25 
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randomized controlled trials of dynamic resistance training lasting ≥6 weeks, ≥2 times 
per week, and ≥30% of 1 repetition maximum, as well as 3 randomized controlled trials 
of IRT lasting ≥8 weeks, ≥2 times per week, and ≥30% MVC reported a significant 
SBP/DBP reduction (4/4 mmHg) in normotensive groups, while in hypertensive groups, 
the reduction of (4/2 mmHg) was not significant (Cornelissen et al., 2011). It should be 
noted that only 6 studies (4 dynamic resistance exercise and 2 IRT) in the meta-analysis 
examined the effects of resistance exercise on BP in the hypertensive population 
(Cornelissen et al., 2011). However, recent studies on dynamic resistance exercise 
training in the hypertensive population have shown a more consistent resting BP-
lowering effect. A study conducted by da Cunha Nascimento and colleagues (2014) in 
older, hypertensive women (n = 12; age = 67 ± 6 years; resting BP = 130/81 ± 8/8 
mmHg) reported mean reductions in SBP/DBP by an average of 18/10 mmHg after 12 
weeks of dynamic resistance exercise. Likewise, a study conducted by Moraes and 
colleagues (2012) in hypertensive, middle-aged men (n = 15, age = 46 ± 3 years, resting 
BP = 150/93 ± 3/2 mmHg) reported significantly reduced SBP/DBP by an average of 
16/12 mmHg following 12 weeks of dynamic resistance exercise. It important to note that 
this study had more repetitions and less rest between sets in comparison to other dynamic 
resistance exercise training protocols in the past, which could account for the increased 
magnitude of BP reductions (Moraes et al., 2012).   
Numerous studies provide compelling evidence that IRT results in reductions of 
resting BP in a variety of populations (Millar et al., 2014; Carlson et al., 2014; Lawrence 
et al., 2015). A meta-analysis of 11 randomized control trials (6 IHG and 5 IL studies) 
lasting >3 weeks, ≥3 times per week, at varying intensities (8%-40% MVC, 75%-95% of 
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maximum HR achieved during an MVC) assessed the IRT effect on resting BP in 
normotensive and hypertensive individuals (n = 302; age ≥18 years) (Inder et al., 2016). 
The mean reductions observed after IRT were 5 mmHg in SBP and 4 mmHg in DBP 
(Inder et al., 2016).  
In general, IRT for ≥8 weeks demonstrate a larger reduction in SBP (7 vs. 3 
mmHg) and MAP (4 vs. 2 mmHg) in comparison to those who trained for <8 weeks, with 
no difference for change in DBP between the duration categories (Inder et al., 2016). It 
has also been reported by Millar and colleagues (2014) that there is a strong correlation 
between the magnitude of change following IRT and baseline BP, such that the greatest 
reductions are observed in those with higher pre-training BP. No IHG trials lasting longer 
than 10 weeks have been reported, which makes the BP response to IHG beyond 10 
weeks unknown (Lawrence et al., 2015). In addition, there is little information on the 
volume of IHG training needed to maintain BP adaptions after a significant reduction in 
BP is achieved (Lawrence et al., 2015). In the only known study investigating the effects 
of IHG training frequency, Badrov and colleagues (2013a) examined the effects of IHG 
training 3 (IHG3) or 5 (IHG5) times per week (four, 2-minute unilateral IHG contractions 
at 30% MVC for 8 weeks) on BP reductions in normotensive women (IHG3 group: n = 
12; age = 23 ± 4 years; resting BP = 94/57 ± 6/7 mmHg; IHG5 group: n = 11; age = 27 ± 
6 years; resting BP = 97/57 ± 11/7 mmHg). Although both groups produced equivalent 
reductions of 6 mmHg in SBP at the conclusion of the 8-week intervention, only the 
IHG5 group experienced significant BP-lowering after 4 weeks of training. However, 
nothing is known about how much IRT is required in other populations to retain BP 
adaptions once a significant BP reduction is achieved (Lawrence et al., 2015).  
 
 
 
 
 27 
Despite the apparent effectiveness of IHG training on resting BP, there is data to 
suggest that there is inter-individual variability in training responsiveness. Millar and 
colleagues (2008) found that post-menopausal women experienced greater training-
induced reductions in resting BP in comparison to age-matched men. In contrast, Somani 
(2015), as well as Badrov and colleagues (2016) provided evidence that IHG training is 
equally effective in reducing resting BP in young normotensive men and women. In 
addition, the recent meta-analysis by Inder and colleagues (2016) found that men reduce 
MAP more than women (4 mmHg vs. 2 mmHg), while there were no significant 
differences for change in SBP, DBP, or HR between men and women. Inder et al. (2016) 
also noted that individuals ≥45 years of age experience larger reductions in MAP than 
those <45 years of age with IHG training (6 mmHg vs. 3 mmHg) (Inder et al., 2016).  
Although not as commonly studied, IL exercise appears to elicit similar BP-
lowering benefits in normotensives despite it being less investigated in comparison to 
IHG. Previous studies have used a wide range of IL training intensities, either based on 
the participant’s MVC force (20-50%), using a specific percentage of maximum HR 
achieved during an MVC, or by measuring muscle activation using electromyography 
(EMG) (10-30% of peak EMG) (Gill et al., 2015; Inder et al., 2016). The typical training 
protocol consists of four, 2-minute bouts of double-leg isometric exercise separated by 3-
minute rest periods, 3 times per week for 4 to 8 weeks (Gill et al., 2015).  
Inder and colleagues (2016) reported, in their meta-analysis, that participants 
undertaking IL training demonstrated a smaller reduction in SBP in comparison to IHG 
training (4 vs. 7 mmHg) (Inder et al., 2016). Devereux and colleagues (2010) observed 
mean reductions in both SBP/DBP of 5/3 mmHg in a normotensive population (n = 13; 
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age = 21 ± 2 years; resting BP = 120/69 ± 12/4 mmHg) following 4 weeks of bilateral leg 
training conducted 3 times per week. The training protocol involved four, 2 minute 
sustained leg extensions at 24% of MVC. Similarly, Baross and colleagues (2012) 
investigated the effects of high intensity (14% MVC) IL training in comparison to low 
intensity (8% MVC) IL training in healthy middle-aged men (14% MVC group: n = 10; 
age = 55 ± 5 years; resting BP = 139/78 ± 7/6 mmHg; 8% MVC group: n = 10; age = 54 
± 5 years; resting BP = 137/78 ± 5/5 mmHg), performed 3 times per week for 8 weeks 
(four, 2 minute bilateral leg contractions). Those who trained at high intensity (14% 
MVC) experienced mean SBP and MAP reductions of 11 and 5 mmHg, respectively, 
with no change in DBP. Conversely, the low intensity group (8% MVC) did not 
experience significant reductions in BP (Baross et al., 2012). IL training has yet to be 
investigated in the hypertensive population, requiring additional research to determine its 
efficacy as a method of HTN control/management.  
A growing body of evidence suggests that IHG training is particularly beneficial 
to individuals with HTN. This work has contributed to the endorsement of IHG training 
as an alternative form of HTN management (Brook et al., 2013; Leung et al., 2016), as 
previously noted (see Section 1.3). It has been reported that hypertensive participants 
experience greater mean reductions of MAP in comparison to normotensive participants 
(6 vs. 3 mmHg), while there were no significant differences for change in SBP or DBP 
between populations (Inder et al., 2016). Taylor and colleagues (2003) examined the 
effects of IHG training on resting BP in older adults with uncontrolled HTN (n = 9; age = 
69 ± 6 years; resting BP = 156/82 ± 9/9 mmHg) with 75% of participants taking 
antihypertensive medication at the time. IHG was performed 3 times per week for 10 
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weeks, with training consisting of four, 2-minute bilateral contractions at 30% MVC. 
IHG training resulted in a significant reduction in SBP (156 ± 9 mmHg to 137 ± 8 
mmHg) and MAP (107 ± 9 mmHg to 96 ± 9 mmHg). Although there was a downward 
trend in DBP, the difference was not statistically significant. Investigators did not 
separate the medicated and non-medicated participants, and as a result, there is no way of 
differentiating the exact response of medicated and non-medicated BP adaptations to IHG 
in this population.   
Three studies have examined the effects of IHG on medicated hypertensives with 
borderline to uncontrolled HTN (McGowan et al., 2006b; Millar et al., 2013; Badrov et 
al., 2013b). In the study by Millar et al. (2013), participants (n = 13; age = 65 ± 6 years; 
resting BP = 125/78 ± 12/2 mmHg) conducted four, 2-minute unilateral bouts at 30% 
MVC, 3 times per week for 8 weeks. IHG training resulted in a significant reduction in 
SBP (125 ± 3 mmHg to 120 ± 2 mmHg) and MAP (90 ± 2 mmHg to 87 ± 2 mmHg). 
Similarly, Badrov et al. (2013b) trained participants (n = 12; age = 65 ± 7 years; resting 
BP = 129/72 ± 16/9 mmHg) 3 times per week for 10 weeks (four, 2-minute bilateral 
bouts at 30% MVC). IHG training resulted in significant reductions of SBP (129 ± 16 
mmHg to 121 ± 16 mmHg), MAP (91 ± 11 mmHg to 85 ± 10 mmHg), and DBP (72 ± 9 
mmHg to 67 ± 8 mmHg). In a similar aged cohort, McGowan et al. (2006b) examined the 
effects of 8-weeks of bilateral (n = 7; age = 62 ± 4 years; resting BP = 134/73 ± 5/3 
mmHg; four, 2-minute bilateral bouts at 30% MVC with 1-minute rest periods) or 
unilateral (n = 9; age = 66 ± 6 years; resting BP = 142/80 ± 4/4 mmHg; four, 2-minute 
unilateral bouts at 30% MVC with 4-minute rest periods) IHG training on resting BP. 
Investigators reported post-training SBP reductions compared to baseline with bilateral 
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training (134 ± 5 mmHg to 118 ± 4 mmHg) and unilateral training (142 ± 4 mmHg to 132 
± 4 mmHg). DBP remained unchanged from baseline after both interventions, while 
MAP was not reported.  
The effect of exercise on ambulatory BP is under-investigated. Recent meta-
analyses of randomized controlled trials suggest that aerobic exercise can produce mean 
reductions in daytime ambulatory SBP/DBP for normotensives and hypertensives of 
approximately 3/3 mmHg and 7/5 mmHg, respectively, but it does not affect nighttime 
BP in either population (Cornelissen et al., 2013; Fagard, 2006). Only two studies to date 
have examined ambulatory BP following a dynamic resistance exercise protocol 
(Blumenthal et al., 1991; Van Hoof et al., 1996). No changes in ambulatory BP measures 
were shown in either a hypertensive or normotensive population, but the lack of data 
addressing the issue makes any conclusion premature.  
There have only been two studies examining the effects of IRT on ambulatory BP 
(Somani et al., 2017; Stiller-Moldovan et al., 2012). Somani and colleagues (2017) 
reported that 10 weeks of IHG training (four, 2-minute bilateral contractions at 30% 
MVC) in young normotensive men (n = 13; age = 24 ± 4 years; resting BP = 117/65 ± 5/7 
mmHg) and women (n = 11; age = 25 ± 5 years; resting BP = 103/62 ± 5/8 mmHg) led to 
significant reductions in mean 24-hour (men: 4 mmHg; women: 4 mmHg), daytime 
(men: 3 mmHg; women: 4 mmHg), and nighttime (men: 4 mmHg; women: 3 mmHg) 
ambulatory SBP measures. Additionally, these reductions in ambulatory BP were 
associated with reductions in resting SBP in both men and women (Somani et al., 2017). 
In contrast, Stiller-Moldovan and colleagues (2012) trained well-controlled medicated 
hypertensive participants (n = 11; age = 60 ± 9 years; resting BP = 114/61 ± 13/12 
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mmHg) using the traditional bilateral IHG protocol for 8 weeks. IHG training did not 
significantly change ambulatory BP, but there were clinically relevant reductions in mean 
24-hour (3 mmHg) and nighttime SBP (4 mmHg). As mentioned in Section 1.2.6, 
reductions as slight as 2 mmHg in SBP have been shown to significantly reduce stroke 
and ischemic heart disease related mortality (Lewington et al., 2002). Additionally, IHG 
training did not significantly change resting SBP and DBP in either group (Stiller-
Moldovan et al., 2012). The BP lowering effects of the antihypertensive medication may 
have hindered the BP reduction response in this sample. Since there were no significant 
reductions in resting BP found in the study, it is not known whether reductions in resting 
BP from IRT are associated with reductions in ambulatory BP as well. A longer training 
duration or a higher frequency of training may have elicited significant reductions in BP 
in this population, however this is speculative as their BP is already well controlled on 
antihypertensive medication. Further investigation is warranted to determine whether 
IHG training attenuates ambulatory BP in normotensive and well-controlled hypertensive 
populations. 
The mechanisms responsible for many of the observed aerobic and resistance 
training-induced reductions in BP remain equivocal (Pescatello et al., 2005; Queiroz et 
al., 2010; Millar et al., 2014).  A reduction in SNS activity from aerobic exercise training 
may hinder NE release, reducing vascular resistance and BP (Pescatello et al., 2005). BP 
reductions from aerobic exercise are also thought to occur through local mechanisms, 
such as increased NO release and a reduction in circulating ET-1 constriction factor, 
resulting in decreased TPR and BP (Pescatello et al., 2004). Chronic dynamic resistance 
exercise does not seem to modify TPR or SNS activity, which makes the mechanisms for 
 
 
 
 
 32 
the BP reductions unclear at this time (Queiroz et al., 2010).  
Prominent hypothesized mechanisms of IRT-induced BP reduction include 
improved modulation of the ANS and well as enhanced vascular function. Heart rate 
variability (HRV) is a simple and effective non-invasive method used to measure ANS 
activity (Sztajzel, 2004). Taylor and colleagues (2003) reported significant improvements 
in HRV in hypertensives concomitant to the BP reductions previously reported (see 
Section 1.3.2), which suggests improved autonomic balance following the 10 weeks of 
IHG training. In contrast, Badrov et al., (2013a) found no changes in HRV following BP-
lowering IHG training in a similar cohort. Consequently, the role of the ANS in IRT-
induced reductions in BP remains unclear.  
Flow-mediated dilation (FMD) is an indirect measure of endothelial function and 
correlates with post-exercise reductions in TPR (Harvey et al., 2005). McGowan and 
colleagues (2006b) investigated the effects of IHG training on FMD in medicated 
hypertensives following 8 weeks of bilateral (n = 7; age = 62 ± 4 years; resting BP = 
134/73 ± 5/3 mmHg) or unilateral (n = 9; age = 66 ± 6 years; resting BP = 142/80 ± 4/4 
mmHg) IHG training conducted 3 times per week. The investigators observed that 
endothelium dependent vasodilation improved locally only within the trained limbs of 
participants, concluding that improvements in endothelial function were not systemic and 
likely did not play a role in the IHG training-induced BP reductions in this cohort.   
In contrast, Badrov and colleagues (2013a) reported that 8 weeks of IHG training 
in young normotensive women conducted 3 times per week (IHG3 group: n = 12; age = 
23 ± 4 years; resting BP = 94/57 ± 6/7 mmHg) and 5 times per week (IHG5 group: n = 
11; age = 27 ± 6 years; resting BP = 97/57 ± 11/7 mmHg) revealed reductions in SBP and 
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improvements in resistance vessel endothelial function. However, McGowan et al. (2007) 
found no changes in FMD in young normotensives (n = 13; age = 28 ± 14 years; resting 
BP = 119/65 ± 7/7 mmHg) following 8 weeks of IHG training, however FMD reflects 
peak dilatory response and not basal-level changes in vascular function. Differences of 
these studies may provide insight into the BP-reducing mechanism of IRT. Comparing 
the older medicated hypertensive group (McGowan et al., 2006b) to the younger 
normotensive group (McGowan et al., 2007), it is possible that in the former group, the 
pharmacological effect on NO release from the medication was enhanced by the 
isometric stress, resulting in an improved FMD (Lawrence et al., 2015).  
1.4 Cardiovascular Reactivity 
Of great and recent interest, there is accumulating evidence to suggest that in 
normotensive individuals of all ages, cardiovascular reactivity to simple cardiovascular 
stressors (e.g., a simple math task known as the serial subtraction task (SST), or a 2-
minute IHG task) can predict the responsiveness to IRT (Millar et al., 2009; Somani 
2015). Cardiovascular reactivity refers to the magnitude of change observed in BP and 
HR measurements during exposure to the stressor from baseline or resting measures 
(Gerin et al., 2000). It is hypothesized that acute BP elevations in response to a stressor 
with repeated exposure can produce chronic elevations in resting BP over time and 
subsequently lead to the development of HTN (Gerin et al., 2000). 
Somani (2015) investigated the relationship between cardiovascular reactivity and 
IHG-training induced reductions in resting BP in a young normotensive cohort of men (n 
= 13; age = 24 ± 4 years; resting BP = 117/65 ± 5/7 mmHg) and women (n = 13; age = 25 
± 5 years; resting BP = 103/62 ± 5/8 mmHg). Reductions in resting SBP in both men and 
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women were significantly correlated with SBP reactivity to a 2-minute IHG task. 
Therefore, individuals with higher SBP reactivity (greater increase in SBP during the 
IHG task compared to baseline value) were shown to have the greatest reductions in SBP 
over the 10 weeks of training, while those with lower SBP reactivity produced modest 
reductions in SBP over 10 weeks. However, the reductions in SBP measures were not 
correlated with the SST (Somani, 2015). In contrast, Millar and colleagues (2009) 
reported that cardiovascular reactivity to the SST was significantly correlated with IHG 
training-induced changes in resting BP in older normotensive participants (n = 17; age = 
62 ± 2 years; resting BP = 125/69 ± 4/1 mmHg) following 8 weeks of IHG training. A 
possible reason for the discrepancy is that younger participants may have a different 
cardiovascular response to SST in comparison to the older participants.  
Badrov et al. (2013b) investigated whether cardiovascular reactivity to the SST 
and the IHG task was associated with IHG training-induced changes in resting BP in 
hypertensive individuals (n = 12; age = 65 ± 7 years; resting BP = 129/72 ± 16/9 mmHg). 
The investigators demonstrated that both stressors were predictive of IHG training 
responsiveness. Furthermore, like the SST, the IHG may be a promising tool to identify 
individuals in this cohort that will respond favourably to IHG training.  
SBP reactivity to either the SST or the IHG task, however, is not predictive of 
reductions in 24-hour ambulatory SBP in the young, normotensive population (Somani et 
al., 2017). However, this work is preliminary, and predicting reductions in ambulatory 
BP via cardiovascular stressors has yet to be explored in the hypertensive population.  
1.5 Detraining Effects on Blood Pressure 
 Aerobic, dynamic resistance, and IRT have all been shown to significantly reduce 
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BP (Brook et al., 2013). However, the effect on BP once chronic exercise training has 
stopped, known as training cessation or detraining, is much less conclusive. The BP 
lowering effects of aerobic exercise training has been shown to diminish within the early 
weeks following training cessation, causing BP to return to baseline values (Meredith et 
al., 1990; Murray et al., 2006). For example, a study by Murray and colleagues (2006) 
assessed the effect of 4 weeks of aerobic exercise (cycle ergometry; 30 minutes at 60% 
maximum oxygen consumption, 3-4 times per week) on young normotensive men (n = 
17; age = 22 ± 2 years; resting BP = 121/66 ± 7/6 mmHg). The 4-week exercise protocol 
resulted in significant reductions in SBP (121 ± 7 mmHg to 107 ± 6 mmHg) and DBP (66 
± 6 mmHg to 53 ± 7 mmHg), but BP readings returned to pretraining levels within 2 
weeks following training cessation (Murray et al., 2006). The same pattern has been 
observed in rats, with a significant decrease in BP during the aerobic training protocol, 
and a time-dependent increase of BP to baseline values during the detraining period 
(Kilic-Erkek et al., 2016). Only two studies have examined the detraining effect of 
aerobic exercise on ambulatory BP. In the studies by Somers et al. (1991) and Zanettini et 
al. (1997), aerobic exercise conducted for 6 months and 4 months in hypertensive 
participants resulted in a significant reduction in resting SBP and DBP, as well as 24-
hour SBP and DBP, but these values returned to baseline 4 months and 2 months after 
training cessation, respectively. The results emphasize the importance of continued 
aerobic exercise as part of a healthy lifestyle in the HTN population or in individuals at 
risk for HTN. 
Recent studies on dynamic resistance exercise training in the hypertensive 
population have shown a significant impact on BP reduction. As reported in Section 
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1.3.2, the study conducted by Moraes and colleagues (2012) in hypertensive, middle-aged 
men reported significantly reduced SBP/DBP following 12 weeks of dynamic resistance 
exercise. BP values remained low during a 4-week detraining period. This was the first 
resistance exercise study to examine the effects of detraining on BP in hypertensive 
individuals. Likewise, a study conducted by da Cunha Nascimento and colleagues (2014) 
in older hypertensive women (see Section 1.3.2) demonstrated training-induced 
reductions in resting BP after a 12-week dynamic resistance program were also sustained 
after 4 weeks of detraining.  
Four studies have reported on the effects of detraining following IRT.  As 
reported in Section 1.3.2, Wiley and colleagues (1992) found significant reductions in 
resting SBP following 5 weeks of IHG training in young normotensive participants. 
These reductions were reversed after only 2 weeks of detraining and gradually returned to 
pre-training values after 5 weeks (the time course of the training period) (Wiley et al., 
1992). More recently, a study by Howden and colleagues (2002) conducted IL training 
(four, 2-minute bilateral bouts at 20% MVC) in young normotensive participants (n = 8, 
age = 21 ± 1 years; resting BP = 121/70 ± 10/7 mmHg) 3 times per week for 5 weeks. 
The significant mean reduction in resting SBP (10 mmHg) was lost after 10 days of 
detraining (Howden et al., 2002). In a study by Devereux and colleagues (2010), the 
detraining effect was also observed from IL training (four, 2-minute bilateral bouts at 
24% MVC, 3 times per week for 4 weeks) in young, normotensive participants (n = 13; 
age = 21 ± 2 years; resting BP = 120/69 ± 12/4 mmHg). Significant mean reductions in 
resting SBP (5 mmHg) were lost after 7 days of training cessation (Devereux et al., 
2010). Conversely, a sub-study by McGowan (2006a) in medicated hypertensive 
 
 
 
 
 37 
participants (n = 9; age = 66 ± 6 years; resting BP = 142/80 ± 4/4 mmHg) reported that 
training-induced SBP reductions were maintained in 5 participants followed over a 
detraining period. These reductions were maintained following both 4 weeks and 8 weeks 
of training cessation. Although the results should be interpreted with caution due to the 
small sample size, these preliminary findings suggest HTN status and/or anti-
hypertensive medication may play a role in the discrepant findings.   
1.6 Summary 
In summary, HTN is a major prognostic indicator of CVD, affecting over 26.4% 
of adults worldwide, and responsible for almost 14% of deaths globally  (WHO, 2017; 
Kearney et al., 2005; Lawes et al., 2008). Randomized controlled trials have convincingly 
shown that a reduction of 5 mmHg in SBP can reduce the risk of coronary heart disease 
by 8%, stroke by 13%, heart failure by 14%, and all-cause mortality by 6% (Ettehad et 
al., 2016).  Meta-regression analyses have also shown relative risk reductions for major 
CVD events (stroke, heart failure, and all-cause mortality) to be proportional to the 
magnitude of BP reduction achieved (Ettehad et al., 2016; Lewington et al., 2002). These 
findings are critical because clinically meaningful reductions as slight as 2 mmHg in SBP 
have been shown to significantly reduce stroke and ischemic heart disease related 
mortality (Lewington et al., 2002). In addition, reductions in nighttime BP have been 
associated with increased rates of a normal dipping pattern, significantly lower rates of 
CVD, and a decreased rate of all-cause mortality (Mehta & Drawz, 2011). For a myriad 
of reasons, current pharmacological and/or lifestyle interventions for HTN management 
are not effective for everyone, and numerous individuals with HTN in North America are 
living with uncontrolled HTN (Wang & Vasan, 2005; Campbell et al., 2013). This is 
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concerning, as uncontrolled BP substantially increases the risk for HTN-related, often 
fatal complications. This creates the need for novel and effective BP-lowering treatment 
tools such as IHG training, which has proven effective in both normotensive and 
hypertensive populations (Inder et al., 2016; Carlson et al., 2014; Millar et al., 2014), that 
can be used alone or in conjunction with traditional strategies.  
Individuals with higher resting BP appear to experience the greatest reductions in 
post-BP (Badrov et al., 2013a; Millar et al., 2007), highlighting the potential therapeutic 
benefit for those with BP above clinical target ranges. Gaining insight into how much 
training is needed to sustain the BP-lowering effects of IRT has significant clinical 
applicability, yet remains inconclusive. Furthermore, the cardiovascular reactivity 
response to an IHG task may be a promising tool to identify individuals that will respond 
favourably to IHG training.  
In conclusion, IHG training has been shown to reduce both resting and 
ambulatory BP in hypertensive individuals with 8 weeks of training, yet the effects of 
detraining on BP in this population warrants further investigation. In addition, 
cardiovascular reactivity to an IHG task to predict the effectiveness of IHG training in 
reducing ambulatory BP in this patient cohort has yet to be explored.  
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2.1 Introduction 
Cardiovascular disease (CVD) refers to all disorders of the heart and circulatory 
system that interfere with efficient functioning (Go et al., 2014). CVD is the leading 
cause of death globally, representing 31% of deaths in 2012 (WHO, 2017), and 29% of 
Canadian deaths in the year 2008 (Statistics Canada, 2015a). It is estimated that by the 
year 2030, CVD will be responsible for 23 million deaths worldwide (WHO, 2017). 
Hypertension (HTN), or high blood pressure (BP) is a major prognostic risk factor for the 
development of CVD and has been deemed a global health crisis by the World Health 
Organization (WHO) (WHO, 2013). In Canada, 1 in 5 people have HTN, and it is the 
number one reason why adults visit their health care provider (Wilkins et al., 2010; 
Hemmelgarn et al., 2008). In Windsor-Essex County, 27% of individuals aged 45-64 
years and 48% of individuals aged 65 years and older were reported to have high BP in 
2012 (Windsor-Essex County Health Unit, 2017). Upwards of 50% of individuals treated 
for HTN in Canada and the United States are not controlled to clinical targets, putting 
these individuals at even greater risk of hypertensive complications (Wilkins et al., 2010; 
Chobanian et al., 2003). Taken together, it is not surprising that the WHO now considers 
the early prevention and treatment of HTN key global priorities (WHO, 2017).  
Meta-regression analyses have shown that a reduction of 5 mmHg in SBP can 
reduce the risk of coronary heart disease by 8%, stroke by 13%, heart failure by 14%, and 
all-cause mortality by 6% (Ettehad et al., 2016). Current treatment and prevention 
interventions for BP control include lifestyle modifications and pharmacotherapy, with 
dietary modifications and increased physical activity as important components (Khan et 
al., 2007; Brook et al., 2013). In spite of the proven benefits of exercise in controlling BP, 
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only 1 in 5 Canadians are meeting physical exercise guidelines (Statistics Canada, 
2015b). Common barriers for those who do not exercise include lack of time and/or 
energy (Ebben & Brudzynski, 2008). In addition, antihypertensive medication is not 
always an effective solution for everyone (Colley et al., 2011). The poor adherence 
and/or lack of responsiveness to traditional treatment require the need for novel and 
effective BP-lowering treatments. 
One such intervention is isometric handgrip (IHG) training, a novel form of 
isometric resistance training (IRT) recently endorsed by the American Heart Association 
(Brook et al., 2013) and Hypertension Canada (Leung et al., 2016), consisting of four, 2-
minute sustained bilateral handgrip contractions at 30% of maximum voluntary 
contraction (MVC) conducted 3-5 times per week for 8-10 weeks. Numerous small-scale 
proof-of-concept studies have provided evidence for the BP-lowering effectiveness of 
this simple and non-time consuming intervention in a variety of populations, including 
men and women, normotensive and hypertensive individuals, and those medicated for 
HTN (Inder et al., 2016; Millar et al., 2014). The most recent meta-analysis of IRT 
reported mean reductions of resting systolic BP (SBP) and diastolic BP (DBP) of 5/4 
mmHg, respectively (Inder, et al., 2016). Millar and colleagues (2014) have also reported 
that there is a strong correlation between the magnitude of change following IRT and 
baseline BP, such that the greatest reductions are observed in those with higher pre-
training BP. 
Ambulatory BP monitoring is now widely recognized as superior to resting 
automated office BP (AOBP) measures for its prognostic and diagnostic ability in clinical 
care (Pickering, 2006; Leung et al., 2016). For example, the dipping pattern (change in 
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BP from daytime to nighttime measures) available with the use of ambulatory BP 
monitoring has become an increasingly important prognostic parameter for CVD risk 
(O’Brien et al., 2001; Boggia et al., 2011). This dipping pattern can be used to monitor 
treatment after initiation and determine the efficacy of antihypertensive therapies 
(Mahabala et al., 2013). However, the effects of IRT on ambulatory BP have been 
minimally investigated. In the only published trials to date, significant post-training 
reductions in mean 24-hour SBP were observed in young healthy adults (Somani et al., 
2017), while clinically relevant reductions were noted in a well-controlled HTN cohort 
(Stiller-Moldovan et al., 2012) following IHG training interventions.  
Many healthcare professionals turn immediately to pharmaceutical treatments of 
HTN, primarily because adherence to dietary and exercise strategies is so poor (Carlson 
et al., 2014; Brook et al., 2013). With respect to the latter, the relatively short sessions 
required for IHG training and the ability to train anywhere are advantages that may 
produce greater exercise adherence in comparison to traditional aerobic or dynamic 
resistance training (Carlson et al., 2014). Moreover, seeing as the only cost is the actual 
purchase of the handgrip dynamometer, IHG training has the potential to be significantly 
more cost-effective over a lifetime in comparison to antihypertensive medication 
(Carlson et al., 2014).  
As with many BP-lowering methods, IHG training is particularly effective in 
individuals with higher pre-training resting BP values (including medicated 
hypertensives), as noted above, and in those ≥45 years of age (Inder et al., 2016). 
Moreover, normotensive and hypertensive individuals with high pre-training SBP 
reactivity to cardiovascular stress tasks (e.g., simple math task; 2-minute IHG task) also 
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appear highly responsive to IHG training (Millar et al., 2009; Badrov et al., 2013; 
Somani, 2015). In other words, those with greater increases in SBP during the acute 
stress task have the greatest reductions in resting SBP with IRT. The predictive effects 
were not carried over to ambulatory BP reductions in normotensive individuals (Somani 
et al., 2017). Cardiovascular reactivity as a predictor of IHG training effectiveness to 
ambulatory BP has yet to be investigated in hypertensive individuals. This highlights the 
need to explore the cardiovascular reactivity to ambulatory BP in this population, since a 
simple cardiovascular stress task may help clinicians identify those who will respond to 
IHG training with a reduction in resting and ambulatory BP.  
Gaining insight into the optimal training frequency/duration needed to sustain the 
effects of IRT has significant clinical applicability, as does gaining insight into the 
tolerability of the intervention from a patient perspective over the long-term. With respect 
to training cessation, studies by Howden et al. (2002) and Devereux et al. (2010) found 
that reductions in SBP (means of 5-12 mmHg) in the normotensive population were lost 
after only 7-10 days of detraining. However, the exercise intervention for each study was 
only 5 weeks and 4 weeks, respectively. On the contrary, McGowan (2006a) found that 
the SBP reductions after 8 weeks of IHG training were maintained following 8 weeks of 
training cessation in medicated hypertensives. These findings must be interpreted with 
caution because of the small sample sizes. The effect of detraining following IRT on 
ambulatory BP has yet to be explored, and no study to date has attempted to gain insight 
into IRT as a feasible and sustainable BP-lowering intervention over the long-term from a 
patient perspective.   
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2.2 Purpose and Hypotheses 
The purpose of this prospective investigation was to fill gaps in the current IRT 
literature by addressing the following in a poorly controlled medicated hypertensive 
population:  
1.   To investigate the concomitant BP-lowering effects of 8 weeks of IHG training on 
resting and ambulatory BP. 
2.   To explore the effect of 4 weeks of training cessation on resting and ambulatory 
BP. 
3.   To determine if SBP reactivity to an IHG task could predict IHG training-induced 
reductions in resting and ambulatory BP. 
4.   To gain knowledge about the feasibility of IHG training as a long-term BP-
lowering treatment from a patient perspective. 
It was hypothesized that: 
1.   8 weeks of IHG training would elicit concomitant reductions in resting and 
ambulatory BP. 
2.   A detraining period of 4 weeks following 8 weeks of IHG training would cause 
resting and ambulatory BP to return to near pre-training values. 
3.   SBP reactivity to an IHG task at baseline would be predictive of IHG 
responsiveness, such that participants who responded to the IHG task with the 
greatest increases in SBP would experience the greatest reductions in resting and 
ambulatory BP. 
4.   IHG will be well received as a long-term BP-lowering tool. 
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2.3 Methods 
Study Participants 
 
 Individuals with Stage 1 HTN with treated resting automated office BP (AOBP) 
above the normal range (120-159/80-99 mmHg) were recruited from Windsor, Ontario, 
Canada and surrounding communities (Appendix A). Participants were excluded if they 
had any hospitalization within the last 3 months, any medication change within the last 2 
months or over the course of the intervention period, a planned absence or vacation 
lasting longer than 1 week, BP readings rising into Stage 2 HTN, secondary HTN, lack of 
primary care provider support, and/or physical limitations that would impair exercise 
performance. The University of Windsor Research Ethics Board approved the study 
(Appendix B, C, D), and all participants provided written informed consent prior to 
participation, as well as ongoing consent throughout the entirety of the intervention.  
Eligibility and Familiarization   
Visit 1 
Individuals who expressed interest in the study met study investigators in the 
Physical Activity and Cardiovascular Research Laboratory (PACR Lab – HK 240, 
University of Windsor, Windsor, ON, Canada). Following explanation of all parts of the 
study, medical history was obtained via a brief questionnaire in consented participants 
(Appendix E). Any questions or concerns regarding the study were answered, and 
participants were informed of their right to withdraw at any time. Next, resting BP and 
heart rate (HR) were measured using standard laboratory protocol following 10 minutes 
of seated rest with an automated brachial artery oscillometric device (Ogedegbe & 
Pickering, 2010; Dinamap Carescape v100, Critikon, Tampa, Florida, USA; Appendix F). 
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In brief, a cuff was placed around the upper dominant arm and inflated to a pressure 
greater than the SBP in order to occlude the brachial artery (Badrov et al., 2013). Four 
measures were obtained, with 2-minute rest intervals between each measure. The first 
measure was discarded and the final three measures averaged to assess eligibility. If 
participants met the resting BP threshold, Visit 2 was scheduled.  
Visit 2 
 At least 24 hours following Visit 1, potential participants returned to the PACR 
Lab. The second visit began by measuring resting BP and HR as previously described 
(see Section: Visit 1). If the average resting AOBP values from Visits 1 and 2 were 
between 120-159/80-99 mmHg, participants underwent a familiarization session during 
which the participant was able to experience all techniques employed during the 
investigation. This served to habituate participants to the testing protocol and minimize 
the effects of anxiety or unfamiliarity on testing variables. At the completion of Visit 2, 
individuals were provided with a physical activity readiness medical examination 
(PARmed-X; Appendix G) to be completed by their health care provider (e.g. physician 
or nurse practitioner). This document also asked the health care provider if the participant 
had primary or secondary HTN. In addition, all participants received two letters for their 
health care provider:  
•   a notification of the participant’s involvement in the study and; 
•   an acknowledgement of this participation to be signed by the participant’s 
health care provider (Appendix H).  
Health care provider support was the final requirement for study eligibility.  
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Testing 
 Upon establishment of eligibility, baseline testing occurred to assess AOBP. All 
testing was conducted in a quiet, temperature-controlled room (20°C - 23°C) following a 
24-hour abstinence from alcohol consumption and vigorous activity, a 12-hour abstinence 
from caffeine, 4 hours post-prandial, and with a voided bladder (Somani et al., 2017).  
Testing was repeated at the same time of day following 8 and 12 weeks. On each testing 
day, resting AOBP and HR were assessed as described previously (see Section: Visit 1). 
On the baseline-testing day only, participants conducted a 2-minute bout on an IHG (2 
minutes at 30% of their maximum voluntary contraction (MVC); ZonaPLUS, Zona 
HEALTH, Boise, Idaho, USA; Appendix I.), referred to as the IHG task. During the 2-
minute bout, BP and HR measurements were recorded at 40 seconds, 80 seconds, and 
120 seconds during the task and averaged to assess cardiovascular reactivity (Gerin et al., 
2000). On the 12-week testing day only, participants completed an exit feasibility scan 
(Appendix J). Participants completed the scan seated at a table, in isolation with a pen 
and paper.  
 At the conclusion of each laboratory testing session (baseline, after week 8, after 
week 12), participants were fitted with a 24-hour ambulatory BP monitor (SpaceLabs 
90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, Washington, 
USA; Appendix K). For 24 hours, BP was measured and recorded every half hour during 
waking hours (6 AM to 10 PM) and every hour during nighttime hours (10 PM to 6 AM) 
(Stiller-Moldovan et al., 2012; Somani et al., 2017). In order to ensure standardization of 
diet and activities during pre-IHG training, post-IHG training, and post-IHG detraining, 
participant diet and activities during the 24-hour period were recorded and discussed with 
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participants (Appendix L). This diet and activity level was revisited and encouraged 
during the post-IHG training and post-IHG detraining measure of ambulatory BP (Stiller-
Moldovan et al., 2012; Somani et al., 2017).  
Training 
Participants trained on the IHG 3 times per week for 8 weeks using the traditional 
protocol, whereby four sets of 2-minute IHG contractions were performed on a 
programmed handgrip dynamometer at 30% of MVC using alternate hands, with each 
contraction separated by a 1 minute rest period (Badrov et al., 2013; Carlson et al., 2014). 
An exercise trainer in the PACR Laboratory supervised two training sessions per week, 
while the third session was completed in the participant’s home. Participants were 
provided detailed written instructions on how to complete the IHG exercise to ensure 
proper at-home training and completed training log books, in which the date of exercise 
completion, MVC scores for each training session, and final compliance scores were 
recorded (Appendix M). To ensure participant safety and preparedness for isometric 
exercise, resting BP and HR were measured (see Section: Visit 1) prior to each training 
session (this data was not used for analysis). Any changes in exercise, diet, supplements, 
and medication were recorded in the log book, and were discussed with participants at 
each laboratory visit to ensure these potentially confounding variables remained 
unchanged throughout the 12-week intervention period (Appendix N). Participants also 
signed the logbook at each visit to ensure ongoing consent, and HTN-related health care 
provider visits were recorded. A registered nurse monitored the BP and HR 
measurements over the course of the study, as well as participant’s medical history to 
ensure safety.  
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 Following the 8 weeks of training, participants ceased training for a 4-week 
period. Participants still came into the PACR Lab two times per week to have their 
resting AOBP and HR measured (see Section: Visit 1), and any changes in diet, exercise, 
supplements, or medication were discussed.  
Statistical Analysis 
 Dependent t-tests were used to examine the training and detraining effects of IHG 
training on resting AOBP (SBP, DBP, MAP), ambulatory BP (24-hour, daytime and 
nighttime), as well as resting and ambulatory HR. Therefore, time was the independent 
variable and BP and HR were the dependent variables. In regard to the ambulatory data 
analysis, any BP measure greater than 2 standard deviations away from the daytime or 
nighttime mean (given the time of the measurement) was omitted (Staessen et al., 1991). 
Post-hoc repeated measures ANOVA were used to determine power for all significant 
resting and 24-hour ambulatory BP changes. 
Cardiovascular reactivity (SBP, DBP, and HR responses) to the IHG task was 
calculated as the difference between the average IHG task-induced values and the mean 
baseline testing values (Gerin et al., 2000). To determine the relationship between 
cardiovascular reactivity and IHG training effects, Pearson correlation coefficients 
between the cardiovascular reactivity values and the residualized IHG SBP change were 
assessed. Since pre-training resting BP and the magnitude of BP reduction following IHG 
training are correlated (Millar et al., 2007), residualized changes in SBP were used, and 
were obtained by regressing pre-post training changes in SBP on pre-training SBP. The 
regression analysis was performed for both resting and ambulatory SBP. Bivariate 
correlation was used to determine the relationship between pre-IHG training resting SBP 
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and the change in resting SBP following 8 weeks of IHG training.  
Repeated measures ANOVA were used to determine the change in average MVC 
per training session over the IHG training period. All data were analyzed using IBM 
SPSS Statistics 23 software (SPSS Inc., Chicago, Illinois, USA) and statistical 
significance was determined at P ≤ 0.05. See Appendix O for Statistical Analysis.  
2.4 Results 
Participant Baseline Characteristics 
Of the 6 individuals recruited, 4 were deemed eligible to participate. Participant 
baseline characteristics are displayed in Table 1. All 4 participants trained for 8 weeks 
and completed 24 IHG sessions. Compliance to maintaining 30% MVC throughout IHG 
bouts was 97%, while the average MVC was 61 (in equipment units). No changes in 
MVC were observed over the training period (P > 0.05). There were no reported changes 
in exercise, diet, or medication throughout the intervention period.  
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Table 1. Participant baseline characteristics 
Characteristics Participants (n = 4) 
 
Women 
 
2 
Age (years) 58 ± 2 
Height (cm) 168 ± 5 
Weight (kg)  74 ± 6 
BMI (kg/m2)  27 ± 3 
Resting SBP (mmHg) 134 ± 14 
Resting DBP (mmHg)  77 ± 10 
Resting MAP (mmHg) 96 ± 11 
Resting HR (beats/minute) 60 ± 5 
Ambulatory Measures 
24-hour SBP (mmHg) 
24-hour DBP (mmHg) 
24-hour MAP (mmHg) 
24-hour HR (beats/min) 
 
135 ± 14 
83 ± 9 
101 ± 8 
64 ± 4 
Medication Classification: 
Calcium channel blocker 
ACE Inhibitor + Calcium channel blocker 
ACE Inhibitor + β-blocker 
Diuretic  
 
1 
1 
1 
1 
 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
MAP, mean arterial pressure; HR, heart rate; ACE, angiotensin converting enzyme. 
Values are mean ± SD.  
 
Effects of Isometric Handgrip Training and Detraining on Resting Blood Pressure 
and Heart Rate 
Following 8 weeks of IHG training, resting SBP (P = 0.352), DBP (P = 0.787), 
MAP (P = 0.731), and HR (P = 0.792) remained unchanged (see Table 2). The 
relationship between pre-training IHG resting SBP and the change in SBP following IHG 
training is shown in Figure 1 (r = -0.904, P = 0.096). A 4-week cessation post-IHG 
 
 
 
 
 74 
training resulted in no changes in resting SBP (P = 0.513), DBP (P = 0.127), MAP (P = 
0.242), and HR (P = 0.639) between post-IHG training and post-IHG detraining (see 
Table 2). Additionally, resting SBP, DBP, MAP, and HR remained unchanged from pre-
IHG training to post-IHG detraining (all P > 0.05, see Table 2). Individual changes in 
resting SBP, DBP, and MAP over the time course of the study are shown in Figure 2.   
Table 2. Resting cardiovascular adaptations to isometric handgrip training and detraining 
 
Participants (n = 4) 
 
Pre-IHG 
Training 
Post-IHG 
Training 
Post-IHG 
Detraining 
Resting SBP (mmHg) 134 ± 14 128 ± 7 123 ± 15 
Resting DBP (mmHg) 77 ± 10 78 ± 5 70 ± 5 
Resting MAP (mmHg) 96 ± 11 95 ± 5 88 ± 8 
Resting HR (beats/minute) 60 ± 5 60 ± 3 59 ± 2 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
MAP, mean arterial pressure; HR, heart rate. Values are mean ± SD; all P > 0.05. 
 
 
Figure 1. Relationship of pre-IHG training resting SBP and the change in resting systolic 
blood pressure (SBP) after isometric handgrip (IHG) training; r = -0.904, P = 0.096.  
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Figure 2. The effect of isometric handgrip (IHG) training and detraining on resting (A) 
systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), and (C) mean arterial 
pressure (MAP); all P > 0.05. 
100
110
120
130
140
150
160
Pre-IHG 
Training
Post-IHG 
Training
Post-IHG 
Detraining
R
es
tin
g 
SB
P 
(m
m
H
g)
ID #1
ID #2
ID #3
ID #4
60
65
70
75
80
85
90
Pre-IHG 
Training
Post-IHG 
Training
Post-IHG 
Detraining
R
es
tin
g 
D
BP
 (m
m
H
g)
ID #1
ID #2
ID #3
ID #4
75
80
85
90
95
100
105
110
115
Pre-IHG 
Training
Post-IHG 
Training
Post-IHG 
Detraining
R
es
tin
g 
M
A
P 
(m
m
H
g)
ID #1
ID #2
ID #3
ID #4
 
 
 
 
 76 
Effects of Isometric Handgrip Training and Detraining on Ambulatory Blood 
Pressure, Heart Rate and Dipping Status 
After 8 weeks of IHG training, 24-hour, daytime, and nighttime ambulatory SBP, 
DBP, MAP, and HR, as well as dipping, remained unchanged (all P > 0.05, see Table 3). 
A detraining period of 4 weeks directly following 8 weeks of IHG training resulted in no 
changes in 24-hour, daytime, and nighttime ambulatory SBP, DBP, MAP, and HR 
between post-IHG training and post-IHG detraining (all P > 0.05, see Table 3). In 
contrast, there was a statistically significant reduction in daytime ambulatory MAP from 
pre-IHG training to post-IHG detraining (P = 0.022). Excluding daytime MAP, 24-hour, 
daytime, and nighttime ambulatory SBP, DBP, MAP, and HR between pre-IHG training 
and post-IHG detraining remained unchanged (all P > 0.05, see Table 3). Individual 
changes in 24-hour, daytime, and nighttime ambulatory SBP over the time course of the 
study are shown in Figure 3.   
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Table 3. Ambulatory cardiovascular adaptations to isometric handgrip training and 
detraining 
 
Participants (n = 4) 
 
Pre-IHG 
Training 
Post-IHG 
Training 
Post-IHG 
Detraining 
24-hour Ambulatory BP 
SBP (mmHg) 
DBP (mmHg) 
MAP (mmHg) 
HR (beats/minute) 
 
135 ± 14 
83 ± 9 
101 ± 8 
64 ± 4 
 
133 ± 9 
83 ± 5 
100 ± 6 
63 ± 5 
 
128 ± 9 
78 ± 4 
95 ± 6 
61 ± 5 
Daytime Ambulatory BP 
SBP (mmHg) 
DBP (mmHg) 
MAP (mmHg) 
HR (beats/minute) 
 
138 ± 13 
87 ± 7 
105 ± 6 
65 ± 5 
 
137 ± 8 
86 ± 5 
103 ± 6 
63 ± 4 
 
132 ± 10 
82 ± 5 
99 ± 7* 
62 ± 6 
Nighttime Ambulatory BP 
SBP (mmHg) 
DBP (mmHg) 
MAP (mmHg) 
HR (beats/minute) 
 
125 ± 18 
72 ± 13 
90 ± 14 
60 ± 5 
 
120 ± 12 
71 ± 7 
88 ± 8 
60 ± 5 
 
115 ± 10 
67 ± 4 
84 ± 5 
57 ± 3 
Dipping 
SBP (%) 
DBP (%) 
MAP (%) 
 
10 ± 5 
17 ± 8 
14 ± 8 
 
13 ± 6 
17 ± 6 
14 ± 6 
 
13 ± 3 
18 ± 1 
15 ± 3 
IHG, isometric handgrip, SBP, systolic blood pressure; DBP, diastolic blood pressure; 
MAP, mean arterial pressure; HR, heart rate. Values are mean ± SD. *Significantly 
different from pre-IHG training; all P < 0.05.  
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Figure 3. The effect of isometric handgrip (IHG) training and detraining on (A) 24-hour, 
(B) daytime, and (C) nighttime ambulatory systolic blood pressure (SBP); all P > 0.05. 
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Cardiovascular Reactivity as a Predictor of Isometric Handgrip Training 
Effectiveness 
 Cardiovascular stress reactivity responses to the IHGT at baseline and the 
relationship to IHG training effects are displayed in Table 4. No associations were 
observed between the reactivity of SBP, DBP, and HR to the IHG task and the 
residualized changes in resting SBP (all P > 0.05). Furthermore, no association was 
observed between any measure of cardiovascular reactivity to the IHG task and training-
induced reductions in 24-hour, daytime, and nighttime ambulatory SBP (all P > 0.05).  
Table 4. Baseline cardiovascular stress reactivity and the relationship to isometric 
handgrip training adaptations 
 ΔSBP 
(mmHg) 
 
r 
 
P 
ΔDBP 
(mmHg) 
 
r 
 
P 
ΔHR 
(bpm) 
 
r 
 
P 
IHGT 19 ± 9 0.584 0.416 11 ± 6 0.705 0.295 5 ± 3 0.456 0.544 
IHGT, isometric handgrip task; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate; bpm, beats per minute. Values are mean ± SD. 
 
Participant’s Perception of Isometric Handgrip Training 
 
 Following the completion of the study, participants were asked to complete 9 
questions regarding their experience with IHG training. The results are presented in Table 
5. It is worth highlighting that all participants (n = 4) strongly agreed with the statements 
regarding IHG training, “I found that training 3 times per week was manageable” and “If 
the option was available, I would continue to train”.  
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Table 5. Participant's perception of isometric handgrip training 
  
Participant (n = 4) Response Frequency: 
Statement: Strongly 
Disagree 
Disagree Undecided Agree Strongly 
Agree 
1. I enjoyed handgrip 
training. 
0 0 0 2 2 
2. I found handgrip training 
challenging. 
0 1 1 2 0 
3. I found that training 3 
times per week was 
manageable. 
0 0 0 0 4 
4. I felt it was difficult 
finding the time to train. 
3 1 0 0 0 
5. If the option were 
available, I would continue 
to train. 
0 0 0 0 4 
6. I would be willing to pay 
for the current cost of a 
handgrip (approximately 
$600.00). 
0 0 3 1 0 
7. I felt better after handgrip 
training for 8 weeks. 
0 0 0 2 2 
8. I believe that my health 
has improved after handgrip 
training for 8 weeks. 
0 0 0 3 1 
9. I would recommend 
handgrip training to others.  
 
0 0 0 2 2 
2.5 Discussion 
The present study is the first to investigate the cardiovascular reactivity to a stress 
task in order to predict changes in ambulatory BP following 8 weeks of IHG training. 
Additionally, findings from the exit scan have provided valuable insight into participant’s 
perspective about IRT in order to guide future studies.  
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Effects of Isometric Handgrip Training and Detraining on Resting and Ambulatory 
Blood Pressure 
 Contrary to hypothesis 1, 8 weeks of IHG training did not elicit a statistically 
significant reduction in resting or ambulatory BP. With respect to resting BP, our 
findings are in disagreement with previous studies examining the effects of IHG on 
medicated hypertensives with borderline to uncontrolled HTN (McGowan et al., 2006b; 
Millar et al., 2013; Badrov et al., 2013). One possible reason for this discrepancy in the 
effectiveness of IHG training to reduce resting BP in medicated hypertensives is that each 
participant was on a different anti-hypertensive medication or a different combination of 
medications. There is limited information on the interaction each medication has with 
exercise, but given the fact that each medication reduces BP through a different 
physiological pathway, it can be speculated that the type of medication can influence the 
BP lowering changes resulting from exercise. Additionally, there is substantial inter-
participant variability when assessing BP changes over the 8-week intervention. As 
shown in Figure 2, participants #3 and #4 had a reduction of 18 mmHg and 12 mmHg in 
resting SBP, respectively. These reductions in resting SBP were consistent with 
concomitant reductions of 16 mmHg and 5 mmHg in nighttime ambulatory SBP as 
shown in Figure 3, respectively. Since BP measurements at night are considered to be 
basal BP and represent the true BP status of an individual (Mahabala et al., 2013), the 
clinically meaningful reductions in nighttime SBP provide insight into the efficacy of 
IHG training in medicated hypertensive individuals. 
Recent research has found that there are inter-individual differences in the 
exercise response given a specific exercise amount and intensity (Bouchard & Rankinen, 
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2001; Hautala et al., 2006; Ross et al., 2015). Moreover, it has been shown that additional 
exercise intensity and/or frequency is needed in certain individuals in order to achieve the 
desired response from exercise, with the desired response ranging from increased 
cardiorespiratory fitness (VO2max) to decreased BP (Bouchard & Rankinen, 2001; Ross et 
al., 2015). Importantly, greater volumes of exercise are associated with a lower 
probability of being a non-responder (Sisson et al., 2009). Therefore, IHG training 3 
times per week may be frequent enough for some individuals to produce a BP-lowering 
effect (participants #3 and #4), but may not be enough for others (participants #1 and #2). 
Consequently, individuals not experiencing a BP-lowering effect from IHG training (non-
responders) may just need a slight increase in exercise frequency and/or intensity in order 
to achieve the BP-lowering effects. The type of medication and/or the combination of 
antihypertensive medications could also have an effect on IHG-responsiveness. 
Participants #3 and #4 had the greatest response to IHG training, both were on different 
medications, with participant #3 being on an ACE inhibitor and β-blocker, while 
participant #4 was taking a diuretic. Although the BP-lowering mechanism has not been 
fully elucidated, diuretics have been shown to decrease total peripheral resistance (TPR) 
(Duarte & Cooper, 2010). In addition, ACE inhibitors, which prevent the formation of the 
vasoconstrictor angiotensin, also decrease TPR (Sweitzer, 2003). It is possible that these 
medication-induced reductions in TPR may have an interaction with the endothelial 
effects of IHG training. The increased vasodilation from diuretics and ACE inhibitors 
may be causing an increased vasodilation following IHG training, which leads to greater 
reductions in BP as seen in participants #3 and #4. 
Participants #1 and #2 had a minimal response to IHG training, and both were 
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taking a calcium channel blocker (Participant #1 was taking this alone, while Participant 
#2 was taking this in addition to an ACE inhibitor). Although this subset of individuals is 
extremely small, it can be speculated that the type of medication could have an effect on 
IHG-training responsiveness. Calcium channel blockers also reduce TPR by binding to L-
type calcium channels on vascular smooth muscle and cardiac tissue to prevent calcium 
ion influx into the cell membrane (Livada & Shiloah, 2013). It is possible that the 
reduction of TPR by calcium channel blockers creates a ceiling effect, which prevents 
IHG training from having long-term endothelial changes in the participants taking this 
medication.  
Although not statistically significant when examined as a cohort, the greatest 
reductions in BP are observed in those with higher pre-training BP, in accordance with 
Millar and colleagues (2014). As shown in Figure 1, participants #3 and #4 had the 
highest baseline resting SBP, and had the greatest reductions in resting SBP. Participants 
#1 and #2 had lower baseline resting SBP, and did not have any reductions in resting 
SBP. Taken together, this still demonstrates the effectiveness of IHG training, especially 
in the poorly controlled hypertensive population who are at greater risk for CVD in 
comparison to others with lower BP.  
A 4-week cessation of training directly following 8 weeks of IHG training 
resulted in no statistically significant changes in resting SBP, DBP, and MAP, or 24-
hour, daytime, and nighttime ambulatory SBP, DBP, and MAP between post-IHG 
training and post-IHG detraining. In the participants that showed a reduction in BP 
following the 8 weeks of training (participants #3 and #4), the reductions in resting SBP 
and MAP, as well as nighttime ambulatory SBP were maintained after the 4 weeks of 
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detraining. These findings are in accordance with the work by McGowan (2006a) in a 
similar cohort of medicated hypertensives after 8 weeks of IHG detraining, but these 
findings must be interpreted with caution because of the small sample size. Other IRT 
studies examining detraining effects in normotensive participants all reported significant 
reductions in BP following the exercise intervention, and all BP values returned to 
baseline following a detraining period of 1-5 weeks (Wiley et al., 1992; Howden et al., 
2002; Devereux et al., 2010). It is worth highlighting that these exercise interventions 
only lasted 4-5 weeks. Millar and colleagues (2014) hypothesized that the rapid nature of 
the detraining effects from the IRT studies suggests that the BP-reducing mechanisms 
responsible influence cardiovascular function rather than structure. Therefore, the 8-week 
exercise intervention in the study by McGowan (2006a) may be enough to influence 
cardiovascular structure in order to produce and maintain BP reductions for at least 4 
weeks post. 
 
Cardiovascular Reactivity as a Predictor of Isometric Handgrip Training 
Effectiveness 
In this study, IHG training effectiveness in lowering resting BP was not shown to 
be associated with cardiovascular reactivity to the IHG task, which is contrary to 
hypothesis 3 and is in disagreement with previous studies that have shown the IHG task 
being associated with IHG training-induced changes in resting BP (Millar et al., 2009; 
Badrov et al. 2013). The combination of the present study being underpowered and the 
fact that no significant changes in resting BP were found after 8 weeks of IHG training 
makes cardiovascular reactivity as a predictor of IHG effectiveness difficult to determine. 
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A possible reason for the discrepancy is the impact of anti-hypertensive medication. For 
example, β-blockers prevent catecholamines from binding to their receptor, causing the 
heart to pump with less intensity, thus reducing HR and BP (Frishman, 2003). Therefore, 
the medication could be the cause for the lack of SBP reactivity to the IHG task (12 
mmHg in comparison to the mean SBP reactivity of 19 mmHg) observed in the 
individual on a β-blocker (participant #3). In addition, all participants were on a different 
combination of anti-hypertensive medication, which all to varying extents reduce TPR 
and/or cause the heart to contract with less intensity. Therefore, it is difficult to compare 
one participant to another because the impact of the medication is different for each 
individual.  
 IHG training effectiveness in lowering ambulatory BP was not shown to be 
associated with cardiovascular reactivity to the IHG task. Of interest, these findings are in 
line with the recent work of Somani and colleagues (2017) in healthy, young adults. It is 
possible that the predictive effects were not carried over to ambulatory BP reductions in 
normotensive and hypertensive individuals because of the inherently high variability of 
BP over a 24-hour period and the difficulty of standardizing extraneous, unanticipated 
factors such as traffic or inclement weather (Somani et al., 2017; Kamarck et al., 2002). 
However, a study with a greater sample size is needed to better understand the effects of 
cardiovascular reactivity on ambulatory BP.  
  
Participant’s Perception of Isometric Handgrip Training 
IHG training is not routinely prescribed in clinical practice (McGowan et al., 
2017), yet there is a significant amount of evidence to show that many people can benefit 
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from this treatment (Inder et al., 2016). In order to shift this paradigm, the feasibility of 
IHG training as a long-term BP-lowering treatment was investigated by having 
participants complete an exit scan following the completion of the study. The time 
efficiency of IHG training was supported by all participants in strong agreement with the 
statement, “I found that training 3 times per week was manageable”, as well as all 
participants in strong disagreement or disagreement with the statement, “I felt it was 
difficult finding the time to train”. Additionally, participants seemed to enjoy IHG 
training, with all participants either in agreement or strong agreement with the statements, 
“I enjoyed handgrip training”, “If the option were available, I would continue to train”, as 
well as, “I would recommend handgrip training to others”. This is important because 
individuals may be more inclined to continue using an exercise modality that they enjoy 
in comparison to one that they do not find pleasant. Moreover, all participants were either 
in agreement or strong agreement with the statements, “I felt better after handgrip 
training for 8 weeks” and “I believe that my health has improved after handgrip training 
for 8 weeks”. Not only are individuals enjoying IHG training on an acute basis during 
training, but also believe they feel better and healthier on a more long-term basis because 
of IHG training. Therefore, it is possible that the simplicity, convenience, and time-
efficiency (i.e., 12 minutes per day, 3 times per week) of IHG training may lead to greater 
adherence in comparison to other traditional forms of anti-hypertensive therapy.  
2.6 Limitations 
 Due to the small sample size and observed power of resting SBP and 24-hour 
ambulatory SBP being 0.086 and 0.129, respectively, inferences cannot be drawn from 
the data and all results should be interpreted with caution. Taking attrition into 
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consideration, a sample size of 30 would have provided sufficient power of 0.8. The low 
power observed in this study limits the probability that null hypotheses would be 
correctly rejected. Although various modalities were used to advertise the study 
throughout the Windsor-Essex community, the substantial time commitment (2-3 times 
per week for 12 weeks) and the specific inclusion/exclusion criteria are examples of 
limiting factors influencing participation. It is possible that a better incentive to 
participant in the research study, for example, a gift card worth more money, may 
facilitate more participants being interested in the study. Although many BP-influencing 
factors were controlled during each testing session, such as diet, caffeine and alcohol 
intake, vigorous exercise, and time of day, that fact that BP was measured at only three 
time points over a 12-week period may limit the precision of the BP readings.   
2.7 Future Research  
A novel and important finding of this study was that participants tended to view 
IHG training as positive, which provides evidence that IHG training is an enjoyable and 
time-effective exercise modality. It is possible that future studies with a greater sample 
size may benefit from having more frequent BP measurement sessions, such as 
measuring resting and ambulatory BP each week, in order to obtain a more precise 
measurement of each participant’s BP. There might also be a benefit to extending the 
length of the study beyond 12 weeks to gain insight into the long-term BP effects 
associated with IHG training.  
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Appendix A — Recruitment Materials 
 
Investigators at the University of Windsor are currently looking for 
individuals on medication for high blood pressure to participate in a study 
examining the effects of isometric handgrip exercise on blood pressure. 
If you are interested and would like more information please contact 
Michael Pearl, BSc: (519)-253-3000 ext. 4979 or pearlm@uwindsor.ca 
 
This study has been cleared by the University of Windsor’s Research Ethics Board 
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Local media/newspaper/email recruitment script: 
"Attention all men and women on medication for high blood pressure. You may be 
eligible to participate in a research study being conducted by investigators at the 
University of Windsor. We are investigating the effects of twelve weeks of isometric 
handgrip exercise training on your blood pressure. For more information please contact 
Michael Pearl at 519-253-3000 ex. 4979 or pearlm@uwindsor.ca." 
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Appendix B — Ethics Approval of Study 
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Appendix C — Consent to Participate in Research 
 
 
Title of Study: Isometric Resistance Exercise to Treat Hypertension 
 
You are asked to participate in a 12-week isometric exercise training research study 
conducted at the University of Windsor. Your total time commitment for the entire study 
is ~ 24 hours: a) determining if you qualify to participate in the study (~1 hour), b) testing 
days (~5 hours total), and c) exercise training (~30 minutes, 3X per week; ~18 hours total). 
 
If you have any questions or concerns about the research at the University of Windsor site, 
please feel to contact Cheri McGowan, PhD (519-253-3000 ext. 2451; 
mcgowanc@uwindsor.ca), or Kevin Milne, PhD (519-253-3000 ext. 2452; 
kjmilne@windsor.ca). For questions or concerns during non-working hours, please contact 
Cheri McGowan, PhD via cell phone at XXX-XXX-XXXX. 
 
PURPOSE OF THE STUDY 
 
In Canada, 1 in 5 people have high blood pressure or resting blood pressure numbers that 
are ≥ 140/90 mmHg, and it is the number one reason why Canadians see their doctor. Many 
people taking medicine for high blood pressure do not have their pressure as low as it 
should be and this is a big problem.  
 
Our research group has shown that isometric (constant squeeze) exercise training using a 
handgrip lowers resting blood pressure in people who have high blood pressure, and even 
in those with normal blood pressure. Squeezing a handgrip for 2 minutes, 4 times, 3 times 
a week for 8 to 10 weeks has been suggested by the American Heart Association as a 
potentially promising new way to lower BP, and also seems to work even in people 
taking blood pressure medication.  
 
Doctors often do not suggest handgrip treatment. This may be because Canadian doctors, 
researchers, and people like yourself living with high blood pressure do not know if 
handgrip treatment also lowers blood pressure during everyday life, if blood pressure 
stays low once the exercise program stops, or for other reasons of which we are unaware. 
Our study will help answer these questions.  
 
In order to participate in this study you must currently be on medication for blood pressure 
and have a resting blood pressure greater than or equal to 120/80 mmHg. Your primary 
health care provider (e.g., family doctor, nurse practitioner) must also agree that it is okay 
for you to participate. If you have been in the hospital in the last 3 months, have changed 
your medication in the past 2 months, plan on being away for longer than 1 week during 
the study period, or have a physical limitation impairing your ability to exercise, you may 
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also be ineligible to participate.  
 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to attend the following: 
 
Visit 1 (approximately 30 minutes): 
You will meet with the study investigators at the Physical Activity and Cardiovascular 
Research (PACR) Laboratory (Room #240, Human Kinetics Building, University of 
Windsor, Windsor, ON, Canada) where you will receive a consent form and information 
sheet about the study. At this time, one of the study investigators will explain all parts of 
the study. If you are still interested in participating in the study, you will be asked to sign 
the consent form and fill out a brief medical questionnaire. You will then have your blood 
pressure measured in your upper arm, similar to how it is taken at a doctor’s office. In brief, 
your resting blood pressure will be measured using an automatic device by placing a cuff 
around your upper dominant arm after 10 minutes of seated rest. Your blood pressure will 
be measured 4 times, with 2-minutes of rest between measures. If your resting blood 
pressure is ≥ 120/80 mmHg, but < 159/99 mmHg your next visit will be scheduled.  
 
Visit 2 (approximately 30 minutes): 
If you are still interested in participating in the study, and you are initially eligible after 
Visit 1, you will visit the lab again.  First, you will have your resting blood pressure 
measured again, in the same manner as the first visit. If your blood pressure is still ≥ 120/80 
mmHg, you will then practice all parts of the study including the handgrip exercise. After 
you practice all parts of the study, you will be asked to complete a physical activity 
readiness questionnaire called a PAR-MedX. You will also receive two letters to be taken 
to your health care provider. One will notify your health care provider of your involvement 
in the study and the second is to be signed by your health care provider and returned to us. 
Upon receiving this document you will then choose the date to complete the Testing Day. 
All testing days will be separated by at least 24 hours.  
 
 
Testing Days (approximately 60 minutes in-lab; 24-hours offsite): 
You will be asked not to exercise vigorously (e.g., exercise that causes you to breathe really 
hard and sweat heavily) or drink alcohol for 24 hours before each testing day, and to avoid 
caffeine for at least 12 hours before. All testing will take place at the same time of day, in 
a quiet, temperature-controlled room, 4 hours after eating. On testing days, you will be 
asked to go to the washroom before testing, as a full bladder can increase your blood 
pressure. 
 
Upon entering the lab, you will first sit at a table and answer 6 to 17 questions on paper. 
You will complete this by yourself, but we will be nearby to answer any questions you may 
have. Next, your resting blood pressure will be measured in the same way that it was 
measured in the previous visits. You will squeeze a handgrip at 30% of your hardest 
squeeze for 2-minutes while your blood pressure is measured. At the end of the testing 
section, we will send you home with a machine that will record your blood pressure for the 
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next 24 hours. The morning following, you will return the device to us. On the final testing 
day, you will be asked to complete an additional exit scan consisting of 11 questions about 
your handgrip training experience.  
 
Training Days (approximately 30 minutes) 
You will be asked to perform 3 handgrip exercises sessions per week, identical to the one 
you performed on Visit 2 (4, 2 minute squeezes, switching hands with each squeeze, with 
a minute of rest between) for 8 weeks. Again, squeezes will be performed at 30% of your 
hardest squeeze. 2 out of the 3 sessions will be performed in the PACR lab, while 1 can be 
done at home. All of your sessions in the lab will be monitored by an exercise trainer, and 
your blood pressure and heart rate will be measured before each session, the same way as 
described above. We will also monitor any changes in diet, exercise or medication at each 
visit on a log sheet, and ask that you sign the log at each visit to show that you still would 
like to be involved with the study. We will also have a form to keep track of how many 
times you go to see your health care provider about your high blood pressure. At the end 
of 8 weeks, you will have your resting and ambulatory blood pressure measured during 
another Testing Day, as described above. 
 
Following 8 weeks of training, you will be randomly (by chance) selected to be in 1 of 2 
groups Depending on your group, you may or may not perform the handgrip for another 4 
weeks. If you are in Group 1, you will continue to train 3 times per week for an additional 
4 weeks. If you are in Group 2, you will not train at all for the additional 4 weeks. At the 
end of this 4-week period, both groups will have a final Testing Day to measure blood 
pressure again. 
 
 Testing	  Hours Initial	  Training	  Phase	  Hours 
Post-­‐Training	  
Phase	  Hours 
TOTAL 
Group	  1 6 12 6 24	  hours 
Group	  2 6 12 4 22	  hours 
 
At the end of each IHG training session, the IHG displays a compliance score out of 100. 
A score >90 needs to be achieved in order for the training session to count. 8 weeks of IHG 
training consists of 24 training sessions (3 times per week). You will need to complete at 
least 80% or 20 training sessions during the 8 weeks in order to remain eligible in the study. 
During the additional 4 weeks of training (12 training sessions) if you are in Group 1, you 
will need to complete at least 80% or 10 training sessions during the 4 weeks in order to 
remain eligible in the study. If you miss a training session during the training period, you 
will be encouraged to make up for the missed training session during the next week of 
training. Each IHG training session should be separated by at least 12 hours. If you miss 
four or more training sessions without making up for any training sessions, or if you go 
seven consecutive days without training, you may continue participating in the study, but 
your data will not be used for full analysis. If you are out of town for an extended period 
of time, you will be encouraged to bring an IHG device with you and continue your normal 
training routine. If you plan on being away during the study period for longer than 1 week, 
it is encouraged that we wait until you are back before we start the training protocol.  
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POTENTIAL RISKS AND DISCOMFORTS 
 
You may experience tendonitis in the tendons of the exercising arms with handgrip exercise 
however this risk is low if the exercise is properly performed. You may experience 
numbness and/or tingling in your arm or hand while the cuff(s) are inflated during our 
measurements. Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions or concerns. 
Study investigators will reinforce proper exercise technique throughout the study. If you 
experience any adverse effects during any testing procedure, emergency responses will be 
provided.  
 
POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY 
 
You may or may not experience a lower blood pressure at rest or during your activities of 
daily life after each part of the study. If handgrip training lowers blood pressure in the 
people in our study, other patients may use it if their blood pressure is higher than it should 
be despite taking blood pressure medicine. Our work may encourage doctors to suggest 
this exercise to their patients.  
 
COMPENSATION FOR PARTICIPATION 
 
You will be reimbursed for parking during the study, as well as for money paid to have 
your health care provider form completed. You will receive a $20.00 Gift Certificate for 
Canadian Tire and a Human Kinetics T-shirt for your participation. 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. 
 
To ensure your confidentiality, following your consent, you will be assigned an 
identification number. Your name will not be mentioned in any publication or presentation, 
and you will be identified with only your identification number on all collection tools 
(electronic or otherwise), with the exception of the informed consent and health care 
provider documents. All paper data will be stored in the locked laboratory (PACR Lab, 
Room #240, Human Kinetics Building, University of Windsor) of the study investigators. 
Information stored on computer will be password-accessible only. With respect to final 
disposal, all paper records (including medical and physical activity readiness 
questionnaires) will be shredded after 5 years. 
                     
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not, and your participation or lack of it will 
not influence your participation in another study. If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind. If you choose to withdraw, 
in most cases we will ask to use the data collected up to the time of your withdrawal, but 
 
 
 
 
 104 
you can request that any and all of your data be destroyed, again without consequence. The 
investigator may withdraw you from this research if circumstances arise which warrant 
doing so (e.g., change in medication, nutrition or physical activity status). All parking 
expenses and health care provider document expenses incurred to date will be reimbursed.  
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE PARTICIPANTS 
Results will also be posted on the University of Windsor’s Research Ethics Board (REB) 
website (http://www.uwindsor.ca/reb) at completion of the study. 
 
SUBSEQUENT USE OF DATA 
 
These data may be used in subsequent studies, in publications and in presentations 
however your privacy will be upheld with the use of your unique subject identification 
number under all circumstances. 
RIGHTS OF RESEARCH PARTICIPANTS 
 
You may withdraw your consent at any time and discontinue participation without penalty. 
If you have questions regarding your rights as a research subject, contact: Research Ethics 
Coordinator, University of Windsor, Windsor, ON, N9B 3P4; Telephone: 519-253-3000, 
ext. 3948; e-mail: ethics@uwindsor.ca 
 
SIGNATURE OF RESEARCH PARTICIPANT/LEGAL REPRESENTATIVE 
 
I understand the information provided for the study “Application of isometric resistance 
exercise to treat hypertension” as described herein. My questions have been answered to 
my satisfaction, and I agree to participate in this study. I have been given a copy of this 
form. 
 
______________________________________ 
    Name of Participant 
 
______________________________________           ____________________   
     
    Signature of Participant      Date 
 
SIGNATURE OF INVESTIGATOR 
These are the terms under which I will conduct research. 
 
_____________________________________             ___________________    
     
         Signature of Investigator     Date 
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Appendix D — Letter of Information 
 
 
 
Title of Study: Isometric Resistance Exercise to Treat Hypertension 
 
You are asked to participate in a 12-week isometric exercise training research study 
conducted at the University of Windsor. Your total time commitment for the entire study 
is ~ 24 hours: a) determining if you qualify to participate in the study (~1 hour), b) testing 
days (~5 hours total), and c) exercise training (~30 minutes, 3X per week; ~18 hours total). 
 
If you have any questions or concerns about the research at the University of Windsor site, 
please feel to contact Cheri McGowan, PhD (519-253-3000 ext. 2451; 
mcgowanc@uwindsor.ca), or Kevin Milne, PhD (519-253-3000 ext. 2452; 
kjmilne@windsor.ca). For questions or concerns during non-working hours, please contact 
Cheri McGowan, PhD via cell phone at XXX-XXX-XXXX. 
 
PURPOSE OF THE STUDY 
 
In Canada, 1 in 5 people have high blood pressure or resting blood pressure numbers that 
are ≥ 140/90 mmHg, and it is the number one reason why Canadians see their doctor. Many 
people taking medicine for high blood pressure do not have their pressure as low as it 
should be and this is a big problem.  
 
Our research group has shown that isometric (constant squeeze) exercise training using a 
handgrip lowers resting blood pressure in people who have high blood pressure, and even 
in those with normal blood pressure. Squeezing a handgrip for 2 minutes, 4 times, 3 times 
a week for 8 to 10 weeks has been suggested by the American Heart Association as a 
potentially promising new way to lower BP, and also seems to work even in people 
taking blood pressure medication.  
 
Doctors often do not suggest handgrip treatment. This may be because Canadian doctors, 
researchers, and people like yourself living with high blood pressure do not know if 
handgrip treatment also lowers blood pressure during everyday life, if blood pressure 
stays low once the exercise program stops, or for other reasons of which we are unaware. 
Our study will help answer these questions.  
 
In order to participate in this study you must currently be on medication for blood pressure 
and have a resting blood pressure greater than or equal to 120/80 mmHg. Your primary 
health care provider (e.g., family doctor, nurse practitioner) must also agree that it is okay 
for you to participate. If you have been in the hospital in the last 3 months, have changed 
your medication in the past 2 months, plan on being away for longer than 1 week during 
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the study period, or have a physical limitation impairing your ability to exercise, you may 
also be ineligible to participate.  
 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to attend the following: 
 
Visit 1 (approximately 30 minutes): 
You will meet with the study investigators at the Physical Activity and Cardiovascular 
Research (PACR) Laboratory (Room #240, Human Kinetics Building, University of 
Windsor, Windsor, ON, Canada) where you will receive a consent form and information 
sheet about the study. At this time, one of the study investigators will explain all parts of 
the study. If you are still interested in participating in the study, you will be asked to sign 
the consent form and fill out a brief medical questionnaire. You will then have your blood 
pressure measured in your upper arm, similar to how it is taken at a doctor’s office. In brief, 
your resting blood pressure will be measured using an automatic device by placing a cuff 
around your upper dominant arm after 10 minutes of seated rest. Your blood pressure will 
be measured 4 times, with 2-minutes of rest between measures. If your resting blood 
pressure is ≥ 120/80 mmHg, but < 159/99 mmHg your next visit will be scheduled.  
 
Visit 2 (approximately 30 minutes): 
If you are still interested in participating in the study, and you are initially eligible after 
Visit 1, you will visit the lab again.  First, you will have your resting blood pressure 
measured again, in the same manner as the first visit. If your blood pressure is still ≥ 120/80 
mmHg, you will then practice all parts of the study including the handgrip exercise. After 
you practice all parts of the study, you will be asked to complete a physical activity 
readiness questionnaire called a PAR-MedX. You will also receive two letters to be taken 
to your health care provider. One will notify your health care provider of your involvement 
in the study and the second is to be signed by your health care provider and returned to us. 
Upon receiving this document you will then choose the date to complete the Testing Day. 
All testing days will be separated by at least 24 hours.  
 
Testing Days (approximately 60 minutes in-lab; 24-hours offsite): 
You will be asked not to exercise vigorously (e.g., exercise that causes you to breathe really 
hard and sweat heavily) or drink alcohol for 24 hours before each testing day, and to avoid 
caffeine for at least 12 hours before. All testing will take place at the same time of day, in 
a quiet, temperature-controlled room, 4 hours after eating. On testing days, you will be 
asked to go to the washroom before testing, as a full bladder can increase your blood 
pressure. 
 
Upon entering the lab, you will first sit at a table and answer 6 to 17 questions on paper. 
You will complete this by yourself, but we will be nearby to answer any questions you may 
have. Next, your resting blood pressure will be measured in the same way that it was 
measured in the previous visits. You will squeeze a handgrip at 30% of your hardest 
squeeze for 2-minutes while your blood pressure is measured. At the end of the testing 
section, we will send you home with a machine that will record your blood pressure for the 
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next 24 hours. The morning following, you will return the device to us. On the final testing 
day, you will be asked to complete an additional exit scan consisting of 11 questions about 
your handgrip training experience.  
 
Training Days (approximately 30 minutes) 
You will be asked to perform 3 handgrip exercises sessions per week, identical to the one 
you performed on Visit 2 (4, 2 minute squeezes, switching hands with each squeeze, with 
a minute of rest between) for 8 weeks. Again, squeezes will be performed at 30% of your 
hardest squeeze. 2 out of the 3 sessions will be performed in the PACR lab, while 1 can be 
done at home. All of your sessions in the lab will be monitored by an exercise trainer, and 
your blood pressure and heart rate will be measured before each session, the same way as 
described above. We will also monitor any changes in diet, exercise or medication at each 
visit on a log sheet, and ask that you sign the log at each visit to show that you still would 
like to be involved with the study. We will also have a form to keep track of how many 
times you go to see your health care provider about your high blood pressure. At the end 
of 8 weeks, you will have your resting and ambulatory blood pressure measured during 
another Testing Day, as described above. 
 
Following 8 weeks of training, you will be randomly (by chance) selected to be in 1 of 2 
groups Depending on your group, you may or may not perform the handgrip for another 4 
weeks. If you are in Group 1, you will continue to train 3 times per week for an additional 
4 weeks. If you are in Group 2, you will not train at all for the additional 4 weeks. At the 
end of this 4-week period, both groups will have a final Testing Day to measure blood 
pressure again. 
 
 Testing	  Hours Initial	  Training	  Phase	  Hours 
Post-­‐Training	  
Phase	  Hours 
TOTAL 
Group	  1 6 12 6 24	  hours 
Group	  2 6 12 4 22	  hours 
 
At the end of each IHG training session, the IHG displays a compliance score out of 100. 
A score >90 needs to be achieved in order for the training session to count. 8 weeks of IHG 
training consists of 24 training sessions (3 times per week). You will need to complete at 
least 80% or 20 training sessions during the 8 weeks in order to remain eligible in the study. 
During the additional 4 weeks of training (12 training sessions) if you are in Group 1, you 
will need to complete at least 80% or 10 training sessions during the 4 weeks in order to 
remain eligible in the study. If you miss a training session during the training period, you 
will be encouraged to make up for the missed training session during the next week of 
training. Each IHG training session should be separated by at least 12 hours. If you miss 
four or more training sessions without making up for any training sessions, or if you go 
seven consecutive days without training, you may continue participating in the study, but 
your data will not be used for full analysis. If you are out of town for an extended period 
of time, you will be encouraged to bring an IHG device with you and continue your normal 
training routine. If you plan on being away during the study period for longer than 1 week, 
it is encouraged that we wait until you are back before we start the training protocol.  
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POTENTIAL RISKS AND DISCOMFORTS 
 
You may experience tendonitis in the tendons of the exercising arms with handgrip exercise 
however this risk is low if the exercise is properly performed. You may experience 
numbness and/or tingling in your arm or hand while the cuff(s) are inflated during our 
measurements. Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions or concerns. 
Study investigators will reinforce proper exercise technique throughout the study. If you 
experience any adverse effects during any testing procedure, emergency responses will be 
provided.  
 
POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY 
 
You may or may not experience a lower blood pressure at rest or during your activities of 
daily life after each part of the study. If handgrip training lowers blood pressure in the 
people in our study, other patients may use it if their blood pressure is higher than it should 
be despite taking blood pressure medicine. Our work may encourage doctors to suggest 
this exercise to their patients.  
 
COMPENSATION FOR PARTICIPATION 
 
You will be reimbursed for parking during the study, as well as for money paid to have 
your health care provider form completed. You will receive a $20.00 Gift Certificate for 
Canadian Tire and a Human Kinetics T-shirt for your participation. 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. 
 
To ensure your confidentiality, following your consent, you will be assigned an 
identification number. Your name will not be mentioned in any publication or presentation, 
and you will be identified with only your identification number on all collection tools 
(electronic or otherwise), with the exception of the informed consent and health care 
provider documents. All paper data will be stored in the locked laboratory (PACR Lab, 
Room #240, Human Kinetics Building, University of Windsor) of the study investigators. 
Information stored on computer will be password-accessible only. With respect to final 
disposal, all paper records (including medical and physical activity readiness 
questionnaires) will be shredded after 5 years. 
                     
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not, and your participation or lack of it will 
not influence your participation in another study. If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind. If you choose to withdraw, 
in most cases we will ask to use the data collected up to the time of your withdrawal, but 
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you can request that any and all of your data be destroyed, again without consequence. The 
investigator may withdraw you from this research if circumstances arise which warrant 
doing so (e.g., change in medication, nutrition or physical activity status). All parking 
expenses and health care provider document expenses incurred to date will be reimbursed.  
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE PARTICIPANTS 
Results will also be posted on the University of Windsor’s Research Ethics Board (REB) 
website (http://www.uwindsor.ca/reb) at completion of the study. 
 
SUBSEQUENT USE OF DATA 
 
These data may be used in subsequent studies, in publications and in presentations 
however your privacy will be upheld with the use of your unique subject identification 
number under all circumstances. 
RIGHTS OF RESEARCH PARTICIPANTS 
 
You may withdraw your consent at any time and discontinue participation without penalty. 
If you have questions regarding your rights as a research subject, contact: Research Ethics 
Coordinator, University of Windsor, Windsor, ON, N9B 3P4; Telephone: 519-253-3000, 
ext. 3948; e-mail: ethics@uwindsor.ca 
 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
 
_____________________________________      _____________________ 
Signature of Investigator     Date 
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Appendix E — Medical Questionnaire 
 
Last Name _________________________________________  First Name_______________________________________________ 
Height:_______________________ Weight: _______________________ Date of Birth (Month/Yr) ___________________________   
Phone   (             ) ____________________________________________________   Postal Code _____________________________ 
  
FOR EMERGENCY NOTIFY:  Name_________________________  Relationship ________________________________________ 
Address_______________________________________________________  Phone _______________________________________ 
Family Doctor's Name ____________________________________________Date of Last Physical ___________________________ 
 
Please Check Yes or No:                                                                                                                                        Yes  No  
1. Have you ever been hospitalized?.........................................................................................................................................o o 
        If yes, please specify? 
_______________________________________________________________________________________ 
 Have you ever had surgery? .................................................................................................................................................o o 
         If yes, please specify? 
_______________________________________________________________________________________ 
2. Are you presently taking any medications or pills (including aspirin and other over-the-counter medication)?.................o o 
   If yes, please specify? 
_______________________________________________________________________________________ 
 Are you presently taking any vitamins, supplements, and/or herbal supplements? .............................................................o o 
3. Do you have any allergies (medicine, food, bees or other stinging insects)?........................................................................o o 
   If yes, please specify? 
_______________________________________________________________________________________  
4. Have you ever passed out during or after exercise?...............................................................................................................o o 
 Have you ever been dizzy during or after exercise? ..............................................................................................................o o 
 Have you ever had chest pain during or after exercise? .........................................................................................................o o 
 Do you have high blood pressure (hypertension) or low blood pressure (hypotension)? ......................................................o o 
       Have you ever been told that you have a kidney problem? ......................................................................................................o o 
 Have you ever been told that you have joint instability? ........................................................................................................o o 
       Have you ever been told that you have a stomach problem? ....................................................................................................o o 
       Have you ever been told that you have a heart problem? ..........................................................................................................o o 
       Have you ever been told that you have a heart murmur? ..........................................................................................................o o 
 Do you have a machine that regulated your heart beat? ..........................................................................................................o o 
       Have you ever had racing of your heart or skipped heartbeats? ................................................................................................o o 
 Has anyone in your family died of heart problems or a sudden death before age 50? ............................................................o o 
5. Do you have any skin problems (itching, rashes, acne)? .........................................................................................................o o 
       If you get a cut, does it take you a long time to stop bleeding? .................................................................................................o o  
 If you experience a blow to a muscle, do you bruise easily? ...................................................................................................o o  
6. Do you have Diabetes?     o o 
7. Do you have Asthma or any other breathing problems?      .....................................................................................................o o 
                If yes, please specify? 
_______________________________________________________________________________________ 
8. Do you have any type of cardiovascular disease? .....................................................................................................................o o 
    If yes, please specify?_______________________________________________________________________________________ 
9. Have you had any other medical problems (infectious mononucleosis, etc.)? .........................................................................o o 
10. Have you had any medical problems since your last physical? ................................................................................................o o 
11. Do you smoke? ..........................................................................................................................................................................o o 
12.  Do you aerobically exercise (e.g., walking) for > 30 minutes, > 2 times per week? ...................................................................o o 
Please explain any physical limitations that may prevent you from completing this study: 
___________________________________________________________________________________________________________ 
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Appendix F — Resting Blood Pressure and Heart Rate Device 
 
 
 
 
Dinamap Carescape v100, Critikon, Tampa, Florida, USA 
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Appendix G — Physical Activity Readiness Medical Examination 
 
 
Required: Patient’s Hypertensive Status (Choose one þ): 1) Primary Hypertension ☐ 
            2) Secondary Hypertension ☐ 
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Appendix H — Health Care Provider Documents 
 
 
 
HEALTH CARE PROVIDER DOCUMENT 
 
 
Date:  __________________. 
 
 
 
Dear __________________, 
 
 
Your patient, ___________________________________, has expressed interest in 
participating in our research study in the Department of Kinesiology at the University of 
Windsor entitled: Application of Isometric Resistance Training to Treat Hypertension 
(see attached Letter of Information for Consent for details). We ask that you sign the 
attached form and return it to us, along with the PARmed-X (where applicable). 
 
Thank-you for your help, and we appreciate your support. Please do not hesitate to 
contact us if you have any questions or concerns. 
 
 
 
Sincerely, 
Dr. Cheri McGowan, PhD 
Dr. Kevin Milne, PhD 
Assistant Professors 
Department of Kinesiology 
Faculty of Human Kinetics 
University of Windsor 
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Date:  __________________. 
 
 
Dear Drs. McGowan and Milne, 
 
I, ___________________________________, acknowledge that my patient 
___________________________________ has expressed interest in participating in our 
research study in the Department of Kinesiology at the University of Windsor entitled: 
Application of Isometric Resistance Training to Treat Hypertension. I have approved my 
patient’s participation in your study. 
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Appendix I — Isometric Handgrip 
 
 
 
ZonaPLUS, Zona HEALTH, Boise, Idaho, USA 
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Appendix J — Exit Scan 
 
Using the scale from 1 – 5 (see below), please answer questions #1-9 by circling a 
number from 1 to 5.  
1 = Strongly Disagree 
2 = Disagree 
3 = Undecided 
4 = Agree 
5 = Strongly Agree 
 
1) I enjoyed handgrip training. 
 1 2 3 4 5 
 
2) I found handgrip training challenging. 
 1 2 3 4 5 
 
3) I found that training 3 times per week was manageable. 
 1 2 3 4 5 
 
4) I felt it was difficult finding the time to train using the handgrip. 
 1 2 3 4 5 
 
5) If the option was available, I would continue to train using the handgrip.  
 1 2 3 4 5 
 
6) I would be willing to pay for the current cost of a handgrip (approximately $600.00).  
 1 2 3 4 5 
 
7) I felt better after handgrip training for 8 weeks.  
 1 2 3 4 5 
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8) I believe that my health has improved after handgrip training for 8 weeks.  
 1 2 3 4 5 
 
9) I would recommend handgrip training to others. 
 1 2 3 4 5 
 
10) My ideal handgrip training frequency per week would be: Check one þ  
 ☐  0 times per week 
 ☐  1 time per week 
 ☐  3 times per week 
 ☐  5 times per week 
 ☐  7 times per week 
 
11) Do you have anything you would like to add about handgrip training?  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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Appendix K — 24-hour Ambulatory Blood Pressure Device 
 
 
 
 
SpaceLabs Inc., Redmond, Washington, USA 
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Appendix L - Ambulatory Blood Pressure: Diet and Activity Journal 
 
Participant code: ______________________ 
Date: ____________________ 
During the 24-hours your blood pressure is being monitored, please complete the tables 
below based on your diet and activity during this time. 
ACTIVITY LOG 
Examples of activities include: sleeping, walking, gardening, watching television, 
exercising, working etc. 
Time Activity 
12:00am  
1:00am 
2: 
 
2:00am  
3:00am  
4:00am  
5:00am  
6:00am  
7:00am  
8:00am  
9:00am  
10:00am  
11:00am  
12:00pm  
1:00pm  
2:00pm  
3:00pm  
4:00pm  
5:00pm  
6:00pm  
7:00pm  
8:00pm  
9:00pm  
10:00pm  
11:00pm  
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FOOD JOURNAL 
Day (circle one): 1 2 3 
Day of Week: _____________________ 
Please circle which of the following best describes you food intake for this day: 
1)   Typical 2) More than usual  3) Less than usual 
 
Please list any vitamin, mineral or herbal supplements taken (brand, frequency & 
dose): 
______________________________________________________________ 
 
Time Location 
(ex. home, 
cafe) 
All Food and Drink 
(including water) 
Type/Preparation 
 
Amount 
Eaten 
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Day (circle one): 1 2 3 
Day of Week: _____________________ 
Please circle which of the following best describes you food intake for this day: 
1)   Typical 2) More than usual  3) Less than usual 
 
Please list any vitamin, mineral or herbal supplements taken (brand, frequency & 
dose): 
_______________________________________________________________ 
 
Time Location 
(ex. home, 
cafe) 
All Food and Drink 
(including water) 
Type/Preparation 
 
Amount 
Eaten 
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Day (circle one): 1 2 3 
Day of Week: _____________________ 
Please circle which of the following best describes you food intake for this day: 
1)   Typical 2) More than usual  3) Less than usual 
 
Please list any vitamin, mineral or herbal supplements taken (brand, frequency & 
dose): 
_______________________________________________________________ 
 
Time Location 
(ex. home, 
cafe) 
All Food and Drink 
(including water) 
Type/Preparation 
 
Amount 
Eaten 
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Appendix M — Participant Log 
Name:________________________________________________________________ 
 
Date What was 
your 
maximum 
contraction 
value? 
Rightmax       
Leftmax 
Did you 
complete two 
sets with each 
hand? 
(% at end of 
session) 
Have you had any 
new medications 
prescribed to you 
and/or have you 
started to take any 
new over the 
counter products?  
Have you 
had any 
dietary 
changes? If 
yes, please 
describe. 
Have you 
had any 
physical 
activity 
changes? If 
yes, please 
describe. 
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Appendix N – Additional Participant Log  
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“I	  understand	  that	  I	  am	  able	  to	  withdraw	  from	  this	  study	  (Isometric	  Resistance	  
Exercise	  to	  Treat	  Hypertension)	  at	  any	  time.	  Please	  accept	  my	  initials	  below	  as	  an	  
indication	  of	  my	  ongoing	  consent	  to	  participate.”	  
	  
	  
	  
	  
	  
	  
	  
	  
AT	  HOME	  JOURNAL:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Participant	  Code:________________________________________________________	  
Date	   What	  was	  
your	  
maximum	  
contraction	  
value?	  
Rightmax	  	  	  	  	  	  	  
Leftmax	  
Did	  you	  
complete	  
two	  sets	  with	  
each	  hand?	  
(%	  at	  end	  of	  
session)	  
Have	  you	  had	  any	  
new	  medications	  
prescribed	  to	  you	  
and/or	  have	  you	  
started	  to	  take	  any	  
new	  over	  the	  
counter	  products?	  	  
Have	  you	  
had	  any	  
dietary	  
changes?	  If	  
yes,	  please	  
describe.	  
Have	  you	  had	  
any	  physical	  
activity	  
changes?	  If	  yes,	  
please	  describe.	  
	   	   	   	   	   	  
	   	   	   	   	   	  
	   	   	   	   	   	  
	   	   	   	   	   	  
 
 
Date	   Participant	  initials	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Appendix O – Statistical Analysis for Chapter 2 
Effects of IHG Training on Resting Blood Pressure and Heart Rate 
Resting value Pre-IHG to Post-IHG Training – Dependent t-test 
1. Resting SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   134.1667   4   14.47987   7.23994  
Post-­IHG   128.2500   4   6.62417   3.31208  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
5.91667   10.77849   5.38925   -­11.23432   23.06765   1.098   3   .352  
 
2. Resting DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   76.9167   4   10.14479   5.07239  
Post-­IHG   77.8333   4   4.81124   2.40562  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
-­
.91667  
6.20858   3.10429   -­10.79591   8.96257   -­.295   3   .787  
 
 
 
 
 
 
 
 133 
3. Resting MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   96.0000   4   10.71325   5.35662  
Post-­IHG   94.6389   4   4.81199   2.40599  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  Interval  of  
the  Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.36111   7.22729   3.61364   -­10.13912   12.86134   .377   3   .731  
 
 
4. Resting HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   60.3333   4   4.57853   2.28927  
Post-­IHG   59.9167   4   3.37062   1.68531  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
.41667   2.89796   1.44898   -­4.19463   5.02796   .288   3   .792  
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Ambulatory value Pre- to Post-IHG Training – Dependent t-test 
 
1a. 24-hour SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   134.7294   4   14.29104   7.14552  
Post-­IHG   132.9256   4   8.73204   4.36602  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.80375   7.88512   3.94256   -­10.74324   14.35074   .458   3   .678  
 
1b. 24-hour DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   83.3375   4   8.55798   4.27899  
Post-­IHG   82.5623   4   5.00771   2.50385  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
.77521   6.18686   3.09343   -­9.06946   10.61988   .251   3   .818  
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1c. 24-hour MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   100.9559   4   8.43830   4.21915  
Post-­IHG   99.5465   4   6.01732   3.00866  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.40934   4.81155   2.40577   -­6.24690   9.06559   .586   3   .599  
 
1d. 24-hour HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   63.9660   4   4.42377   2.21188  
Post-­IHG   62.6525   4   4.57805   2.28903  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.31341   1.08310   .54155   -­.41005   3.03687   2.425   3   .094  
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2a. Daytime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   137.9430   4   13.00381   6.50190  
Post-­IHG   136.7440   4   8.27054   4.13527  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.19900   8.64398   4.32199   -­12.55551   14.95351   .277   3   .799  
 
2b. Daytime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   87.0031   4   6.77739   3.38870  
Post-­IHG   85.7846   4   4.98145   2.49072  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.21853   5.67946   2.83973   -­7.81877   10.25582   .429   3   .697  
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2c. Daytime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   104.5376   4   6.39980   3.19990  
Post-­IHG   102.8130   4   5.75309   2.87655  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.72454   4.78231   2.39116   -­5.88519   9.33426   .721   3   .523  
 
2d. Daytime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   65.3413   4   4.77629   2.38814  
Post-­IHG   63.4924   4   4.44057   2.22028  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
1.84898   1.67330   .83665   -­.81362   4.51158   2.210   3   .114  
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3a. Nighttime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   124.8507   4   17.94181   8.97091  
Post-­IHG   119.6250   4   11.59966   5.79983  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
5.22569   8.38471   4.19235   -­8.11624   18.56763   1.246   3   .301  
 
3b. Nighttime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   72.2986   4   12.51229   6.25614  
Post-­IHG   71.3125   4   6.60689   3.30345  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
.98611   5.99276   2.99638   -­8.54971   10.52193   .329   3   .764  
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3c. Nighttime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   90.4167   4   14.13792   7.06896  
Post-­IHG   88.1563   4   8.42700   4.21350  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
2.26042   6.10663   3.05332   -­7.45660   11.97743   .740   3   .513  
 
 
3d. Nighttime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   59.7292   4   4.87785   2.43892  
Post-­IHG   59.7188   4   5.17946   2.58973  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
.01042   2.65042   1.32521   -­4.20700   4.22783   .008   3   .994  
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4a. Dipping SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   9.7608   4   4.72622   2.36311  
Post-­IHG   12.5600   4   5.68895   2.84447  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
-­
2.79916  
6.74834   3.37417   -­13.53728   7.93895   -­.830   3   .468  
 
4b. Dipping DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   17.3333   4   7.65393   3.82697  
Post-­IHG   16.8379   4   6.26412   3.13206  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
.49539   3.54290   1.77145   -­5.14217   6.13294   .280   3   .798  
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4c. Dipping MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre-­IHG   13.8611   4   7.89901   3.94951  
Post-­IHG   14.2668   4   6.20863   3.10432  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre-­IHG  -­  
Post-­IHG  
-­
.40569  
5.74363   2.87181   -­9.54508   8.73370   -­.141   3   .897  
 
Cardiovascular Reactivity as a Predictor of IHG Training Effectiveness  
Correlation Analysis 
 
1. Resting SBP 
 
 ΔSBP 
(mmHg) 
 
r 
 
P 
ΔDBP 
(mmHg) 
 
r 
 
P 
ΔHR 
(bpm) 
 
r 
 
P 
IHGT 19 ± 9 0.584 0.416 11 ± 6 0.705 0.295 5 ± 3 0.456 0.544 
 
2a. 24-hour SBP 
 
 IHGT-SBP IHGT-DBP IHGT-HR 
r 0.510 0.968 0.846 
P 0.659 0.162 0.358 
IHGT, isometric handgrip task; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate 
 
2b. Daytime SBP 
 IHGT-SBP IHGT-DBP IHGT-HR 
r -0.571 -0.983 -0.882 
P 0.613 0.117 0.313 
IHGT, isometric handgrip task; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate 
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2c. Nighttime SBP 
 IHGT-SBP IHGT-DBP IHGT-HR 
r 0.479 0.958 0.826 
P 0.682 0.185 0.381 
IHGT, isometric handgrip task; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate 
 
 
Effect of IHG Training on Maximum Voluntary Contraction 
Repeated Measures ANOVA 
 
Tests  of  Within-­Subjects  Effects  
Measure:      MEASURE_1     
Source  
Type  III  Sum  
of  Squares   df   Mean  Square   F   Sig.  
factor1   Sphericity  Assumed   646.560   23   28.111   1.518   .094  
Greenhouse-­Geisser   646.560   2.490   259.648   1.518   .284  
Huynh-­Feldt   646.560   15.613   41.412   1.518   .135  
Lower-­bound   646.560   1.000   646.560   1.518   .306  
Error(factor1)   Sphericity  Assumed   1277.617   69   18.516     
Greenhouse-­Geisser   1277.617   7.470   171.024     
Huynh-­Feldt   1277.617   46.839   27.277     
Lower-­bound   1277.617   3.000   425.872     
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Effects of IHG Detraining on Resting Blood Pressure and Heart Rate 
Resting value Post-IHG Training to Detraining – Dependent t-test 
1. Resting SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   128.2500   4   6.62417   3.31208  
Detraining   123.2500   4   14.92793   7.46397  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  Interval  of  
the  Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
5.00002   13.52911   6.76456   -­16.52781   26.52786   .739   3   .513  
 
2. Resting DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   77.8333   4   4.81124   2.40562  
Detraining   70.1667   4   4.63880   2.31940  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
7.66668   7.31815   3.65908   -­3.97814   19.31149   2.095   3   .127  
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3. Resting MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   94.6389   4   4.81199   2.40599  
Detraining   87.8611   4   7.91487   3.95743  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
6.77779   9.33112   4.66556   -­8.07010   21.62568   1.453   3   .242  
 
4. Resting HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   59.9167   4   3.37062   1.68531  
Detraining   58.7500   4   2.28321   1.14160  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  Interval  of  
the  Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
1.16668   4.49280   2.24640   -­5.98238   8.31573   .519   3   .639  
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Resting value Pre-IHG Training to Detraining – Dependent t-test 
 
1. Resting SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   134.1667   4   14.47987   7.23994  
Detraining   123.2500   4   14.92793   7.46397  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
10.91669   14.98487   7.49243  
-­
12.92757  
34.76096   1.457   3   .241  
 
2. Resting DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   76.9167   4   10.14479   5.07239  
Detraining   70.1667   4   4.63880   2.31940  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  1   Pre_IHG  -­  
Detraining  
6.75000   10.96248   5.48124   -­10.69374   24.19375   1.231   3   .306  
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3. Resting MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   96.0000   4   10.71325   5.35662  
Detraining   87.8611   4   7.91487   3.95743  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
8.13890   12.23345   6.11673   -­11.32725   27.60505   1.331   3   .275  
 
4. Resting HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   60.3333   4   4.57853   2.28927  
Detraining   58.7500   4   2.28321   1.14160  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
1.58334   6.42551   3.21276   -­8.64108   11.80777   .493   3   .656  
 
 
 
 
 
 
 
 
 
 147 
Ambulatory value Post-IHG Training to Detraining – Dependent t-test 
 
1a. 24-hour SBP: 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   132.9256   4   8.73204   4.36602  
Detraining   127.7488   4   8.98379   4.49189  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
5.17689   5.17536   2.58768   -­3.05825   13.41204   2.001   3   .139  
 
1b. 24-hour DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   82.5623   4   5.00771   2.50385  
Detraining   78.0137   4   3.65028   1.82514  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.54865   3.64470   1.82235   -­1.25087   10.34818   2.496   3   .088  
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1c. 24-hour MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   99.5465   4   6.01732   3.00866  
Detraining   95.0728   4   5.77430   2.88715  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.47374   3.03322   1.51661   -­.35280   9.30027   2.950   3   .060  
 
1d. 24-hour HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   62.6525   4   4.57805   2.28903  
Detraining   60.8874   4   5.14356   2.57178  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
1.76516   5.60328   2.80164   -­7.15090   10.68123   .630   3   .573  
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2a. Daytime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   136.7440   4   8.27054   4.13527  
Detraining   131.9696   4   9.79517   4.89758  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.77433   6.99634   3.49817   -­6.35840   15.90707   1.365   3   .266  
 
2b. Daytime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   85.7846   4   4.98145   2.49072  
Detraining   81.8860   4   4.55315   2.27658  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
3.89856   5.02234   2.51117   -­4.09310   11.89022   1.552   3   .218  
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2c. Daytime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   102.8130   4   5.75309   2.87655  
Detraining   98.7285   4   6.82522   3.41261  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.08452   4.54636   2.27318   -­3.14975   11.31879   1.797   3   .170  
 
2d. Daytime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   63.4924   4   4.44057   2.22028  
Detraining   62.4196   4   6.13395   3.06697  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
1.07273   6.81209   3.40605   -­9.76683   11.91229   .315   3   .773  
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3a. Nighttime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   119.6250   4   11.59966   5.79983  
Detraining   115.1563   4   9.97046   4.98523  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.46875   4.26636   2.13318   -­2.31998   11.25748   2.095   3   .127  
 
3b. Nighttime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   71.3125   4   6.60689   3.30345  
Detraining   66.7500   4   3.65006   1.82503  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
4.56250   4.90376   2.45188   -­3.24048   12.36548   1.861   3   .160  
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3c. Nighttime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   88.1563   4   8.42700   4.21350  
Detraining   84.2902   4   5.17727   2.58863  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
3.86607   4.27709   2.13854   -­2.93973   10.67187   1.808   3   .168  
 
3d. Nighttime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   59.7188   4   5.17946   2.58973  
Detraining   56.8929   4   3.48014   1.74007  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
2.82589   3.82747   1.91374   -­3.26447   8.91625   1.477   3   .236  
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4a. Dipping SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   12.5600   4   5.68895   2.84447  
Detraining   12.7503   4   3.42110   1.71055  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
-­
.19031  
4.33369   2.16684   -­7.08617   6.70555   -­.088   3   .936  
 
4b. Dipping DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   16.8379   4   6.26412   3.13206  
Detraining   18.4735   4   1.45434   .72717  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
-­
1.63554  
6.83985   3.41992  
-­
12.51926  
9.24818   -­.478   3   .665  
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4c. Dipping MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Post_IHG   14.2668   4   6.20863   3.10432  
Detraining   14.5599   4   2.74886   1.37443  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Post_IHG  -­  
Detraining  
-­
.29308  
5.66838   2.83419   -­9.31273   8.72658   -­.103   3   .924  
 
Ambulatory value Pre-IHG Training to Detraining – Dependent t-test 
1a. 24-hour SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   134.7294   4   14.29104   7.14552  
Detraining   127.7488   4   8.98379   4.49189  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
6.98064   8.07569   4.03785   -­5.86958   19.83087   1.729   3   .182  
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1b. 24-hour DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   83.3375   4   8.55798   4.27899  
Detraining   78.0137   4   3.65028   1.82514  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.32386   6.11844   3.05922   -­4.41194   15.05966   1.740   3   .180  
 
1c. 24-hour MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   100.9559   4   8.43830   4.21915  
Detraining   95.0728   4   5.77430   2.88715  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.88308   4.49594   2.24797   -­1.27097   13.03713   2.617   3   .079  
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1d. 24-hour HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   63.9660   4   4.42377   2.21188  
Detraining   60.8874   4   5.14356   2.57178  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
3.07857   4.58993   2.29497   -­4.22503   10.38218   1.341   3   .272  
 
2a. Daytime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   137.9430   4   13.00381   6.50190  
Detraining   131.9696   4   9.79517   4.89758  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.97333   6.93388   3.46694   -­5.06002   17.00669   1.723   3   .183  
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2b. Daytime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   87.0031   4   6.77739   3.38870  
Detraining   81.8860   4   4.55315   2.27658  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.11708   3.84522   1.92261   -­1.00151   11.23568   2.662   3   .076  
 
2c. Daytime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   104.5376   4   6.39980   3.19990  
Detraining   98.7285   4   6.82522   3.41261  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.80906   2.64885   1.32443   1.59415   10.02397   4.386   3   .022  
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2d. Daytime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   65.3413   4   4.77629   2.38814  
Detraining   62.4196   4   6.13395   3.06697  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
2.92171   5.48004   2.74002   -­5.79826   11.64167   1.066   3   .364  
 
3a. Nighttime SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   124.8507   4   17.94181   8.97091  
Detraining   115.1563   4   9.97046   4.98523  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
9.69444   12.12081   6.06040   -­9.59246   28.98135   1.600   3   .208  
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3b. Nighttime DBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   72.2986   4   12.51229   6.25614  
Detraining   66.7500   4   3.65006   1.82503  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
5.54861   10.53623   5.26812   -­11.21688   22.31410   1.053   3   .370  
 
3c. Nighttime MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   90.4167   4   14.13792   7.06896  
Detraining   84.2902   4   5.17727   2.58863  
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
6.12649   10.37462   5.18731   -­10.38185   22.63483   1.181   3   .323  
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3d. Nighttime HR: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   59.7292   4   4.87785   2.43892  
Detraining   56.8929   4   3.48014   1.74007  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
2.83631   3.86555   1.93278   -­3.31465   8.98727   1.467   3   .239  
 
4a. Dipping SBP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   9.7608   4   4.72622   2.36311  
Detraining   12.7503   4   3.42110   1.71055  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
-­
2.98947  
6.47338   3.23669   -­13.29007   7.31112   -­.924   3   .424  
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4b. Dipping DBP: 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   17.3333   4   7.65393   3.82697  
Detraining   18.4735   4   1.45434   .72717  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
-­
1.14015  
8.59149   4.29575   -­14.81114   12.53083   -­.265   3   .808  
 
4c. Dipping MAP: 
 
Paired  Samples  Statistics  
 Mean   N   Std.  Deviation   Std.  Error  Mean  
Pair  1   Pre_IHG   13.8611   4   7.89901   3.94951  
Detraining   14.5599   4   2.74886   1.37443  
 
 
Paired  Samples  Test  
 
Paired  Differences  
t   df  
Sig.  (2-­
tailed)  Mean  
Std.  
Deviation  
Std.  Error  
Mean  
95%  Confidence  
Interval  of  the  
Difference  
Lower   Upper  
Pair  
1  
Pre_IHG  -­  
Detraining  
-­
.69876  
9.04178   4.52089   -­15.08625   13.68872   -­.155   3   .887  
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Relationship Between Baseline SBP and SBP Change Following IHG Training 
Bivariate Correlation 
 
Descriptive  Statistics  
 Mean   Std.  Deviation   N  
SBPChange   -­6.0000   10.67708   4  
BaselineSBP   134.2500   14.40775   4  
 
 
Correlations  
 SBPChange   BaselineSBP  
SBPChange   Pearson  Correlation   1   -­.904  
Sig.  (2-­tailed)    .096  
N   4   4  
BaselineSBP   Pearson  Correlation   -­.904   1  
Sig.  (2-­tailed)   .096    
N   4   4  
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Effects of IHG Training on Resting and Ambulatory SBP 
Repeated Measures ANOVA 
 
1. Resting SBP: 
 
Descriptive  Statistics  
 Mean   Std.  Deviation   N  
Pre_IHG   134.1667   14.47987   4  
Post_IHG   128.2500   6.62417   4  
Detraining   123.2500   14.92793   4  
 
 
Multivariate  Testsa  
Effect   Value   F  
Hypothesis  
df  
Error  
df   Sig.  
Partial  Eta  
Squared  
Noncent.  
Parameter  
Observed  
Powerc  
Time   Pillai's  Trace   .436   .773b   2.000   2.000   .564   .436   1.546   .086  
Wilks'  
Lambda  
.564   .773b   2.000   2.000   .564   .436   1.546   .086  
Hotelling's  
Trace  
.773   .773b   2.000   2.000   .564   .436   1.546   .086  
Roy's  
Largest  Root  
.773   .773b   2.000   2.000   .564   .436   1.546   .086  
a.  Design:  Intercept    
  Within  Subjects  Design:  Time  
b.  Exact  statistic  
c.  Computed  using  alpha  =  .05  
 
2. Ambulatory 24-hour SBP: 
 
Descriptive  Statistics  
 Mean   Std.  Deviation   N  
Baseline   134.7294   14.29104   4  
Week8   132.9256   8.73204   4  
Week12   127.7488   8.98379   4  
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Multivariate  Testsa  
Effect   Value   F  
Hypothesis  
df  
Error  
df   Sig.  
Partial  Eta  
Squared  
Noncent.  
Parameter  
Observed  
Powerc  
Time   Pillai's  Trace   .633   1.728b   2.000   2.000   .367   .633   3.455   .129  
Wilks'  
Lambda  
.367   1.728b   2.000   2.000   .367   .633   3.455   .129  
Hotelling's  
Trace  
1.728   1.728b   2.000   2.000   .367   .633   3.455   .129  
Roy's  
Largest  Root  
1.728   1.728b   2.000   2.000   .367   .633   3.455   .129  
a.  Design:  Intercept    
  Within  Subjects  Design:  Time  
b.  Exact  statistic  
c.  Computed  using  alpha  =  .05  
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